$YGYI Focusing on Multiple Product Verticals

• Youngevity offers products in the top eight selling retail categories
• The company offers a hybrid of the direct selling business model
• Youngevity is also developing a line of proprietary, hemp-derived cannabidiol oil products

A top omni-direct lifestyle company, Youngevity International, Inc. (NASDAQ: YGYI) operates in the Direct Selling and Coffee Industry segments. The retail categories in which it participates include health and nutrition, home and family, food and beverage, spa and beauty, fashion, essential oils, photo and unique services. Chula Vista, California-based Youngevity International is among the top 100 global direct selling companies.

Youngevity is concentrating on three diverse growth channels. These encompass expansion into Latin America and…

Read more »

More from NetworkNewsWire

• Universal mCloud Corp. (TSX.V: MCLD) Starts Presentation at LD Micro Main Event
• Noa Botanicals Starts Presentation at LD Micro Main Event
• Edison Nation, Inc. (EDNT) Starts Presentation at LD Micro Main Event

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive instant SMS alerts, text STOCKS to 77948

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

$PBIO New Management Hire to Play Key Role

• Bradford A. Young, Ph.D., MBA was recently appointed senior vice president and chief commercial officer
• A very accomplished and experienced businessman and scientist, Young has helped guide and grow both startups and large companies
• Young is expected to leverage his technical expertise and real-world experience to drive revenue growth via major partnerships and new commercialization programs

A leader in the development and commercialization of innovative, pressure-based technologies for the worldwide life sciences industry, Pressure BioSciences Inc. (OTCQB: PBIO) recently appointed Dr. Bradford A. Young as its senior vice president and chief commercial officer. The move is designed to help drive the company’s revenue growth and expand its commercialization programs by leveraging Young’s experience as both a scientist and a well-connected and experienced businessman.

Speaking about the appointment during a recent Uptick Newswire Stock Day Podcast with…

Read more »

More from NetworkNewsWire

• Universal mCloud Corp. (TSX.V: MCLD) Starts Presentation at LD Micro Main Event
• Noa Botanicals Starts Presentation at LD Micro Main Event
• Edison Nation, Inc. (EDNT) Starts Presentation at LD Micro Main Event

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive instant SMS alerts, text STOCKS to 77948

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

$NUGS Pursues Licensing to Begin Substantial Cultivation Operations in Central California

$TGODF Supply Agreement Provides Opening to Canadian Provincial Cannabis, Liquor Boards

$NUGS Large and Small-Scale Cannabis Cultivation Fueling Growth of Budding Industry

CannabisNewsWire – CannabisNewsWire (“CNW”), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring Cannabis Strategic Ventures (OTC: NUGS), a client of CNW focused on incubating, developing and partnering with category leaders within the cannabis sector.

To view the full publication, titled “Cannabis Cultivation Powering Growth for the Industry,” visit: http://cnw.fm/dtN7O

This interest of Cannabis Strategic Ventures shows how quickly cannabis cultivation has acquired the trappings of a legally established industry. As a publicly traded company that incubates, develops and partners with brands, Cannabis Strategic Ventures is a sort of meta-business that emerges in sophisticated markets — bolstering the development of production, services and retail through its application of business acumen and strategically applied capital.

Cannabis cultivation is a specialist form of agriculture, requiring an understanding of hydroponics, plant strains and environmental factors that affect the potency of crops. Acquiring those skills hasn’t been easy, especially given how long the industry operated in the shadows, its techniques and collective knowledge shared only through illicit channels. As cultivation takes off, the industry needs the support of companies such as Cannabis Strategic Ventures to acquire equipment, train staff and build facilities to meet the demand of a growing customer base.

About Cannabis Strategic Ventures, Inc.

Cannabis Strategic Ventures is a Los Angeles based firm that incubates, develops and partners with category leaders within the cannabis sector. The Firm’s NUGS brand experience provides mentorship and a range of essential services to emerging and existing Cannabis consumer brands. The company recently completed a name and symbol change from Cascade Energy, Inc. Cannabis Strategic Ventures is publicly traded on the U.S. Over the Counter Market with the stock symbol NUGS. For more information, visit the company’s website at www.CannabisStrategic.com.

About CannabisNewsWire (CNW)

CannabisNewsWire (“CNW”) is a specialized information service that (1) aggregates cannabis news, (2) provides CannabisNewsBreaks that quickly updates investors in the space, (3) enhances corporate press releases, (4) helps companies with distribution and optimization of social media, and (5) delivers comprehensive corporate communication solutions. CNW is uniquely positioned in the cannabis market with a strong team of journalists and writers who can help private and public companies reach a wide audience of investors, consumers, journalists and the general public through our ever-growing dissemination network of more than 5,000 key syndication outlets. CNW is bringing unparalleled visibility, recognition and content to the cannabis industry.

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Forward-Looking Statements

This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release and matters set in the company’s SEC filings. These risks and uncertainties could cause the company’s actual results to differ materially from those indicated in the forward-looking statements.

CNW Corporate Communications Contact:
CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net

$NETE 420 with CNW – Why Cannabis Capsules are Gaining Popularity

$VVCIF Canna Farms Wins Top Reviewed Licensed Producer of the Year Award

NAPANEE, Ontario, Dec. 04, 2018 — VIVO Cannabis Inc. (TSX-V: VIVO, OTCQX: VVCIF) (“VIVO” or the “Company”) is pleased to announce that its wholly-owned subsidiary, Canna Farms Limited (“Canna Farms”), was recognized as the Top Reviewed Licensed Producer of the Year at the recent Canadian Cannabis Awards.  The award, announced on November 29, 2018 and chosen by Lift & Co., was based on the overall volume and quality of reviews of Licensed Producers on the Lift.co website.

Dan Laflamme, President of Canna Farms, said, “It is great to be recognized for being good at what you love to do.  This award is a recognition of the Canna Farms team – talented people that deliver the highest quality product with exceptional customer service.”

About VIVO Cannabis™

VIVO, based in Napanee, Ontario, is recognized for trusted, high-quality products and services. It holds production and sales licences from Health Canada and operates world-class indoor cultivation facilities with proprietary plant-growing technology. VIVO has a collection of premium brands targeting unique customer segments, including Beacon Medical™, FIRESIDE™, Canna Farms™ and Lumina™. In August 2018, VIVO acquired Canna Farms, a premium cannabis company based in Hope, British Columbia. Canna Farms was B.C.’s first Licensed Producer and has several years of craft cultivation experience and expertise, as well as a significant patient base and positive cash flow. The Company is significantly expanding its production capacity and pursuing partnership and product development opportunities domestically, as well as in select international markets, including Germany and Australia. VIVO also operates Harvest Medicine, a patient-centric and highly scalable network of specialty medical cannabis clinics as well as a soon to be released free telemedicine app. VIVO has a healthy balance sheet with and is well-positioned to accelerate the growth of our business, in Canada and internationally.

ON BEHALF OF THE BOARD OF DIRECTORS

Barry Fishman (CEO and Director)

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

More Information

Barry Fishman, CEO:                     barry.fishman@vivocannabis.com
Michael Bumby, CFO:                     michael.bumby@vivocannabis.com
Website:                                vivocannabis.com

$NUGS Strengthening Portfolio as Widespread Cannabis Approval Surges

$DPW Coolisys Technologies Receives $1.3 Million in Repeat Contracts

Newport Beach, Calif., Dec. 03, 2018 — DPW Holdings, Inc. (NYSE American: DPW) a diversified holding company, (“DPW” or “the Company”) reported its subsidiary, Coolisys Technologies, Inc. (“Coolisys”) has received two repeat customer contracts valued at $1.3 million.

Recent Contracts

• A $630,000 order with a leading dental technology company for a Power-Plus value-added solution:
  This includes product design, turnkey supply-chain and product fulfillment services that exceeded the customer’s stringent time-to-market and product quality requirements;
• A $400,000 order with a tier-1 medical technology company specifying a custom high-grade AC/DC Digital Power Corporation (“DPC”) power supply. The contract includes design, development, and manufacturing services for the custom medical grade power supply solution to support their next generation endoscopy product line. The selection was based on Coolisys Technologies’ excellence in manufacturing, support, logistics and engineering.

“The success of Coolisys and its business units is driven by our ability to design, develop and deliver cost effective power solutions to highly discerning customers, especially those in the medical and dental industry,” said Mr. Russell Woodmansee, Chief Operating Officer of Coolisys Technologies, Inc. “We offer custom design capability and program management that shortens time-to-market objectives for our customers. Both these customers have increased existing orders, underscoring the quality of our services and our power electronics products. Our team has a long history of operational excellence, helping OEMs get high-level assemblies just in time, while also providing top-notch field repair and support services,” explained Mr. Woodmansee.

About DPW Holdings, Inc.
DPW Holdings, Inc. is a diversified holding company pursuing growth by acquiring undervalued businesses and disruptive technologies that hold global potential. Through its wholly owned subsidiaries and strategic investments, the company provides mission-critical products that support a diverse range of industries, including defense/aerospace, industrial, telecommunications, medical, crypto-mining, and textiles. In addition, the company owns a select portfolio of commercial hospitality properties and extends credit to select entrepreneurial businesses through a licensed lending subsidiary. DPW Holdings, Inc.’s headquarters is located at 201 Shipyard Way, Suite E, Newport Beach, CA 92663; www.DPWHoldings.com.

Forward-Looking Statements
The foregoing release contains “forward looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as “believes,” “plans,” “anticipates,” “projects,” “estimates,” “expects,” “intends,” “strategy,” “future,” “opportunity,” “may,” “will,” “should,” “could,” “potential,” or similar expressions. Statements that are not historical facts are forward-looking statements. Forward-looking statements are based on current beliefs and assumptions that are subject to risks and uncertainties. Forward-looking statements speak only as of the date they are made, and the Company undertakes no obligation to update any of them publicly in light of new information or future events. Actual results could differ materially from those contained in any forward-looking statement as a result of various factors. More information, including potential risk factors, that could affect the Company’s business and financial results are included in the Company’s filings with the U.S. Securities and Exchange Commission, including, but not limited to, the Company’s Forms 10-K, 10-Q and 8-K. All filings are available at www.sec.gov and on the Company’s website at www.DPWHoldings.com.

###

Contacts: 
Mary Magnani and Kirsten Chapman, LHA Investor Relations, 415.433.3777, dpwholdings@lhai.com

$NETE Wins Two Categories at ACQ5 Global Awards 2018, CEO Named “Gamechanger of the Year”

Company Wins Awards for US- Payment Solutions Provider of the Year and US-Scale-up Company of the Year

MIAMI, FL, Dec. 03, 2018  — via NEWMEDIAWIRE – Net Element, Inc. (NASDAQ: NETE) (“Net Element” or the “Company”), a global technology and value-added solutions group that supports electronic payments acceptance in a multi-channel environment including point-of-sale (“POS”), e-commerce, and mobile devices, today announced that it won two categories at ACQ5 Global Awards 2018 and that its CEO Oleg Firer was named “Gamechanger of the Year”.

The ACQ5 Global Awards celebrate the achievement, innovation, and brilliance of outstanding organizations and individuals across the globe. Chosen by members of the industry itself, award winners selected from more than 75,000 nominations include industry leaders, eminent individuals, exemplary teams, and distinguished firms who have had the greatest impact in their industry and represent the benchmark of achievement, professionalism and best practices.

Net Element’s ACQ5 Global Awards 2018 were:

• US – Payment Solutions Provider of the year
• US – Scale-up Company of the year (Payment Solutions)
• US – Gamechanger of the year, Oleg Firer

“Our goal at Net Element is to be exactly as represented by the award we won – a gamechanger for the payments services industry by providing our merchants with seamless multi-channel payment solutions, value added services and creating value for our shareholders,” said Oleg Firer, CEO of Net Element. “We are honored and proud to be recognized by ACQ5 Global for the work we’re doing.”

About ACQ5 Global Awards 

ACQ5 is a leading corporate magazine news site. Serving the finance sector since 2003, ACQ5 provides its Global audience of over 168,000 subscribers with the information behind the headlines.  ACQ5, the English-language magazine news portal is read exclusively by senior executives holding power and authority at major organizations. The magazine is intended for CEO’s & CFO’s as well as other corporate finance and private equity executives from all corners of the globe.  ACQ5 achieves its objectives through non-bias, concentrated, up to date flagship coverage, country reports and multilateral documents, in some cases commissioned by corporate, governmental and multilateral institutions.  ACQ5 is a valuable addition to the sources of expert information required by leading businessmen when they are fine-tuning their corporate strategies.  For more information, please visit www.ACQ5.com or contact ACQ5 at +44(0)871 218 2470.

About Net Element

Net Element, Inc. (NASDAQ: NETE) operates a payments-as-a-service transactional and value-added services platform for small to medium enterprise (“SME”) in the U.S. and selected emerging markets. In the U.S., the Company aims to grow transactional revenue by innovating SME productivity services using various technology solutions and Aptito, our cloud-based, restaurant and retail point-of-sale solution. Internationally, Net Element’s strategy is to leverage its omni-channel platform to deliver flexible offerings to emerging markets with diverse banking, regulatory and demographic conditions. Net Element was ranked as one of the fastest growing companies in North America on Deloitte’s 2017 and 2018 Technology Fast 500™.  In 2017 we were recognized by South Florida Business Journal as one of 2016’s fastest-growing technology companies. Further information is available at www.NetElement.com.

Forward-Looking Statements

Securities Exchange Act of 1934, as amended. Any statements contained in this press release that are not statements of historical fact may be deemed forward-looking statements. Words such as “continue,” “will,” “may,” “could,” “should,” “expect,” “expected,” “plans,” “intend,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” and similar expressions are intended to identify such forward-looking statements. All forward-looking statements involve significant risks and uncertainties that could cause actual results to differ materially from those expressed or implied in the forward-looking statements, many of which are generally outside the control of Net Element and are difficult to predict. Examples of such risks and uncertainties include but are not limited to (i) Net Element’s ability (or inability) to obtain additional financing in sufficient amounts or on acceptable terms when needed; (ii) Net Element’s ability to maintain existing, and secure additional, contracts with users of its payment processing services; (iii) Net Element’s ability to successfully expand in existing markets and enter new markets; (iv) Net Element’s ability to successfully manage and integrate any acquisitions of businesses, solutions or technologies; (v) unanticipated operating costs, transaction costs and actual or contingent liabilities; (vi) the ability to attract and retain qualified employees and key personnel; (vii) adverse effects of increased competition on Net Element’s business; (viii) changes in government licensing and regulation that may adversely affect Net Element’s business; (ix) the risk that changes in consumer behavior could adversely affect Net Element’s business; (x) Net Element’s ability to protect its intellectual property; (xi) local, industry and general business and economic conditions; and (xii) adverse effects of potentially deteriorating U.S.-Russia relations, including, without limitation, over a conflict related to Ukraine, including a risk of further U.S. government sanctions or other legal restrictions on U.S. businesses doing business in Russia. Additional factors that could cause actual results to differ materially from those expressed or implied in the forward-looking statements can be found in the most recent annual report on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K filed by Net Element with the Securities and Exchange Commission. Net Element anticipates that subsequent events and developments may cause its plans, intentions and expectations to change. Net Element assumes no obligation, and it specifically disclaims any intention or obligation, to update any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by law.

Contact:

Net Element, Inc.
+1 (786) 923-0502
www.netelement.com
Media@NetElement.com

Corporate Communications Contact:
NetworkNewsWire (NNW) 
New York, New York 
www.NetworkNewsWire.com
212.418.1217 Office 
Editor@NetworkNewsWire.com

$FRSX Vision System Installed in Leading Automotive OEM’s Vehicle

Foresight Autonomous Holdings Ltd. (Nasdaq and TASE:FRSX), an innovator in automotive vision systems, announced today that it has successfully delivered and installed its first QuadSight™ prototype system for evaluation by a leading European manufacturer of commercial vehicles. QuadSight™ was successfully installed on the manufacturer’s truck and passed all initial performance testing. The customer will continue independent evaluation of the system’s performance.

A CES 2019 Innovation Award Honoree, the QuadSight™ quad-camera vision solution targets semi-autonomous and autonomous vehicles and is designed to allow near-100 percent obstacle detection with near zero false alerts, under any weather or lighting conditions.

By collaborating closely with the vehicle manufacturer at the prototype evaluation stage, Foresight collects important feedback in order to develop a commercial product that fits the exact customer’s requirements. Customer satisfaction at the end of the evaluation process may lead to future orders of QuadSight™systems by the vehicle manufacturer for mass production.

“This successful installation marks an important milestone in Foresight’s roadmap,” said Haim Siboni, CEO of Foresight. “We believe that in-vehicle evaluations of the QuadSight™ vision system will clearly demonstrate its advantage over competing systems by its ability to detect any obstacles under harsh weather and diverse lighting conditions. Such evaluations will increase the customer’s confidence in Foresight’s products.”

Using a four-camera vision system based on stereoscopic technology, QuadSight addresses the real-world need for autonomous driving in all-weather and all-lighting conditions and is designed to provide an unprecedented level of obstacle detection accuracy for semi-autonomous and autonomous vehicle safety. Leveraging decades of field-proven security technology and highly advanced image-processing algorithms, QuadSight™ uniquely enables visibility in complete darkness, snow, rain, fog, sandstorms and blinding glare.

Foresight will offer a live demonstration the QuadSight™ vision system at CES 2019, held from January 8–11 at the Westgate Las Vegas, booth #2206. Contact Foresight to schedule a demo.

About QuadSight™
Foresight first launched a demo of its QuadSight™ system last January at the CES show in Las Vegas. Foresight regards QuadSight™ as the industry’s most accurate quad-camera vision system, offering exceptional obstacle detection for semi-autonomous and autonomous vehicle safety. Using proven, highly advanced image-processing algorithms, QuadSight™ uses four-camera technology that combines two pairs of stereoscopic infrared and daylight cameras. QuadSight™ is designed to achieve near-100% obstacle detection with near zero false alerts under any weather or lighting conditions – including complete darkness, rain, haze, fog and glare.

Stereoscopic vision technology’s exceptional three-dimensional (3D) images, detection and accuracy are essential for safe and reliable semi-autonomous and autonomous vehicle vision systems. The combination of stereoscopic visible-light cameras and thermal vision exceeds a human driver’s ability to see objects in real time, whether large or small, in-motion or static, and from short or long-range distances.

About Foresight
Foresight Autonomous Holdings Ltd. (Nasdaq and TASE: FRSX), founded in 2015, is a technology company engaged in the design, development and commercialization of stereo/quad-camera vision systems and V2X cellular-based solutions for the automotive industry. Foresight’s vision systems are based on 3D video analysis, advanced algorithms for image processing, and sensor fusion. The company, through its wholly owned subsidiary Foresight Automotive Ltd., develops advanced systems for accident prevention which are designed to provide real-time information about the vehicle’s surroundings while in motion. The systems are designed to improve driving safety by enabling highly accurate and reliable threat detection while ensuring the lowest rates of false alerts. The company’s systems are targeting the Advanced Driver Assistance Systems (ADAS), semi-autonomous and autonomous vehicle markets. The company predicts that its systems will revolutionize automotive safety by providing an automotive-grade, cost-effective platform and advanced technology.

Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995 and other Federal securities laws. Words such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” “estimates” and similar expressions or variations of such words are intended to identify forward-looking statements. For example, Foresight is using forward-looking statements in this press release when it discusses future orders of QuadSight systems and the benefits of in-vehicle evaluations. In addition, Foresight is using forward-looking statements when it discusses that it intends to increase awareness of its unique solutions, to address potential customers and expand its presence with vehicle manufacturers and Tier One automotive suppliers by selling additional prototypes. Because such statements deal with future events and are based on Foresight’s current expectations, they are subject to various risks and uncertainties, and actual results, performance or achievements of Foresight could differ materially from those described in or implied by the statements in this press release.

The forward-looking statements contained or implied in this press release are subject to other risks and uncertainties, including those discussed under the heading “Risk Factors” in Foresight’s annual report on Form 20-F filed with the Securities and Exchange Commission (“SEC”) on March 27, 2018, and in any subsequent filings with the SEC. Except as otherwise required by law, Foresight undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. References and links to websites have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this press release. Foresight is not responsible for the contents of third party websites.

$YGYI Hemp-Derived Cannabidiol HempFX Products Now Available Online

• Youngevity International is an amalgam of products and services under one corporate entity
• The company’s global sales are increasing with recent international expansion
• Its three hemp-derived cannabidiol products are now available for online purchase

A foremost omni-direct lifestyle company, Youngevity International, Inc. (NASDAQ:YGYI) focuses on supporting a healthy and empowered lifestyle. The company operates in two major and scalable business segments – direct selling and the coffee industry (via wholly owned subsidiary CLR Roasters). Headquartered in Chula Vista, California, Youngevity generates revenue from the eight leading retail categories. These categories encompass health and nutrition, home and family, food and beverage, spa and beauty, fashion, essential oils, photo and unique services.

Youngevity International is a global Main Street of products and services under one corporate entity. The company offers a fusion of the direct selling business model. This includes e-commerce and…

Read more »

More from NetworkNewsWire

• QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX.V: QMC) (FSE: 3LQ) Nears Completion of Resource Update to Cap Eventful Year at Irgon Project
• Zenergy Brands, Inc. (ZNGY) Gains Loyal Customer Base by Helping Reduce Utility Consumption and Carbon Footprints
• Victory Marine Holdings Corp. (VMHG) Eyes Growth from Branding and Delivery of Personalized Service in Yacht After-Sale Support

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive instant SMS alerts, text STOCKS to 77948

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

$TGODF Building New Capacity upon First Commercial Cannabis Crop

• Full-scale cannabis legalization in Canada in October led to a rush of consumer interest and a resultant shortage of supply as the new industry adapts
• The Green Organic Dutchman is improving on its initial commercial crop by building facilities with 195,000 kilograms of annual production capacity
• The company’s reach includes cultivation facilities in Canada and Jamaica, with additional hemp production in Poland
• Vast distribution capabilities spread wide across Canada, Jamaica, Mexico and Europe

Soaring demand for legal cannabis products has strengthened the long-term outlook for cannabis cultivator The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF), which is expanding its production capability as well as its international footprint in a bid to stay abreast of the market’s sweeping tide.

Canada’s nationwide legalization of cannabis in October opened the doors to a huge buying spree by consumers, even as its newly regulated industry struggled to cross the bar into the unknown expanse of legitimate high-quality marijuana production while the black market outlets that the legal industry threatened to extinguish continued to snap up customers unwilling to wait for the new market’s wheels to turn (http://nnw.fm/acNI8).

Legal cannabis retail outlets in Quebec, Manitoba, New Brunswick, British Columbia, Alberta, Nova Scotia and Saskatchewan reported supply shortages in late November, and Khurram Malik, CEO of diversified cannabis company Biome Grow, predicted that supply might only be adequate to meet demand by 2020 or later, according to the Motley Fool (http://nnw.fm/b47rS).

At the forefront of authorized producers, The Green Organic Dutchman dedicated its first commercial crop to a closed “Grower’s Circle” group of patients and investors as a show of loyalty to “those who supported TGOD and those who are most in need of medical cannabis therapy,” according to its third-quarter operations report. At the same time, the company was working to expand its existing 27,000 square feet of production space in Hamilton, Ontario, into an operation that’s expected to ramp-up to nearly 200,000 kilograms of annual capacity across Ontario, Quebec and Jamaica when construction is completed early next year, as well as scalable hemp capacity in Poland.

The company is improving efficiency measures in its existing commercial cultivation while developing five new strains for the medical and recreational markets amid the race to provide patients and other consumers with consistent, premium product.

The Motley Fool report notes the declining stock values of many cannabis producers following Canada’s transition to legalization, adding that investors may become increasingly unhappy if losses increase while growers continue expanding their capacity and working on product diversification, branding and marketing. That includes The Green Organic Dutchman, which the report describes as a potential top-five producer once it gets running on all cylinders with its expected 195,000 kilograms of annual production (including 40,000 kilogram-equivalents from edibles and cannabis-infused beverages as they become legal).

The Green Organic Dutchman acknowledged in its third quarter report that “expanding its operations, administration and marketing infrastructure to rapidly scale its business” resulted in a loss for the three and nine months ended September 30, but it stated that those losses were in line with budgeted expectations.

Chief Financial Officer Sean Bovingdon noted in the third quarter report that The Green Organic Dutchman “has secured its financial future by raising over $450 million [and] fully funding [the company’s] current domestic and international plans,” adding that TGOD has “no plans to return to the market for additional capital at this time.”

Bovingdon continued, “We have de-risked the capital side of our business and with our focus now on delivering medical and recreational sales in Canada and internationally. We expect to drive significant value for shareholders in 2019 and beyond.”

For more information, visit the company’s website at www.TGOD.ca

More from NetworkNewsWire

• ChineseInvestors.com, Inc. (CIIX) to offer Comprehensive Investor Information
• Propagation of Digital Technology Expected to Help Zenergy Brands, Inc.’s (ZNGY) Energy Efficiency Program Reach More People
• Victory Marine Holdings Corp. (VMHG) Anticipates Increased Revenues due to Heightened Industry Presence and Communication with Customers

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive instant SMS alerts, text STOCKS to 77948

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

$NUGL Returns to Money TV

LOS ANGELES, CA, Nov. 30, 2018 — via NEWMEDIAWIRE — NUGL Inc. (OTC: NUGL) (the “Company”), the cannabis industry’s new standard of technology, is pleased to announce its second interview on the venerable financial program, Money TV.

“We had to get back on the air and let the investing public know what we’ve been up to beyond the confines of a press release,” said Ryan Bartette, Chief Marketing Officer, NUGL.  “We now have launched our much-anticipated advertising platform with full reporting analytics 25 days ahead of schedule and even improved the imperative search function.  Our users already love it and we are selling new ads daily, monetizing our ever-growing user traffic.

“For the next few weeks we plan on using the Money TV format to update our current and prospective shareholders on all the roll-outs, development and general progress at NUGL,” added Bartlette.

Stay tuned to the latest NUGL appearances on Money TV at the link below:

http://moneytv.net/this-weeks-show/

About NUGL

NUGL is the world’s first cannabis search app built for the people, by the people. Our goal is to build the most user-friendly app experience in the cannabis industry by listening to our users and giving them what they want. NUGL is the only cannabis search app that offers equal and unbiased search results. We don’t sell top-spot listings or fake reviews, so our data stays true. Use NUGL to search for genuine user-rated dispensaries, strains, doctors, lawyers, cannabis service providers, vape shops, hydro stores, brands and more. NUGL’s flexible web app has no geographic limitations and can rapidly connect cannabis companies, related vertical services and users. The NUGL iOS and Android app brings a powerful cannabis search tool within reach of anyone, anytime, anywhere with the ease of a smartphone.

For more information and updates, visit one of the links below.

Website: http://www.nugl.com/
Facebook:  https://www.facebook.com/nuglapp/
Instagram: https://www.instagram.com/nuglapp/
Twitter: https://twitter.com/nuglapp/

LinkedIn: https://www.linkedin.com/company/nuglapp/

Newsletter: https://nugl.us16.list-manage.com/subscribe?u=219fe8bb6995a19827c9f36cb&id=dc46712578

Forward-Looking Statements

Certain statements in this press release may be considered “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements may include projections of matters that affect revenue, operating expenses or net earnings; projections of growth; and assumptions relating to the foregoing. Such forward-looking statements are generally qualified by terms such as: “plans”, “anticipates,” “expects,” “believes” or similar words of like kind. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or qualified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking information. These factors are discussed in greater detail in the company’s business plan and filings with the OTC Markets Group.

Contact Information:

Website: www.nugl.com 

Email: info@nugl.com 

Phone: (714) 383-9982

Investor Relations & Financial Media

info@integrityir.com

Toll Free: (888) 216-3595

www.IntegrityIR.com

$VVCIF Reports Record Revenue for Q3 2018

• Revenue of $2.3 million
• Pro-Forma Revenue of $4.4 million

NAPANEE, Ontario, Nov. 30, 2018 — VIVO Cannabis Inc. (TSX-V: VIVO, OTCQX: VVCIF) (“VIVO” or the “Company”), a licensed producer of cannabis under the Cannabis Act through its wholly-owned subsidiaries, ABcann Medicinals Inc. (“ABcann”) and Canna Farms Limited (“Canna Farms”), is pleased to announce the release of its financial results for the three and nine months ended September 30, 2018. The results represent the Company’s strongest financial performance to date.

“The acquisition of Canna Farms represents a transformational transaction in the evolution of VIVO that has led to a record quarter of $2.3 million revenue, with $4.4 million of pro forma revenue for the full quarter. Not only has this acquisition provided a significant revenue impact, it has tripled our production capacity, expanded our product range and substantially increased our medical patient base,” stated Barry Fishman, CEO of VIVO.

Q3 2018 Highlights

• Q3 revenue of $2.3 million
• Completion of the acquisition of Canna Farms on August 31, 2018, resulting in pro forma Q3 revenue of $4.4 million (the revenue that VIVO would have reported had Canna Farms been owned for the entire quarter)
• At the end of Q3 2018, total medical cannabis patients of 18,000 compared to 2,000 at the end of Q2 2018 (representing a 9-fold increase)
• Entry into adult-use supply agreements with British Columbia, Alberta, Saskatchewan, Manitoba, Ontario and the Yukon, and Canna Farms achieving one of the best order fulfillment rates in the industry
• Beacon Medical™ product was introduced into the Australian market
• The upgrading of the Company’s common shares to the OTCQX® Best Market in the United States
• Completion of corporate re-branding, including name change to VIVO Cannabis and the launch of the Beacon Medical™ cannabis brand
• Introduction of the Lumina™ and Fireside™ adult-use cannabis brands
• Expansion of senior level management team and appointment of Daniel Laflamme to the Company’s board of directors.

Highlights Subsequent to Q3 2018

• The launch of Harvest Medicine’s HMED Connect telemedicine app, which allows patients across Canada to access Harvest Medicine’s class-leading education and patient-centric model at any time, and is expected to create significant partnership opportunities with pharmacies, long-term care facilities and insurance companies
• Acquisition of Trauma Healing Centres (“THC”), a leading east coast chain of medical cannabis clinics, resulting in Harvest Medicine and THC currently operating six clinic locations across four provinces representing a total of 22,000 active patients
• Strategic equity investments in Canadian cannabis retailers, National Access Cannabis Corp. and Westleaf Cannabis Inc.
• VIVO’s capacity to supply both the medical and adult-use markets will be enhanced in the first half of 2019 with internal expansion in BC and Ontario and through certified third-party partner supply agreements.

Financial Results

VIVO reported revenues of $2.3 million and a net loss of $9.1 million for the third quarter of 2018, as the Company continues to invest to drive future growth. Non-recurring advertising and promotion expenses incurred in preparation for the launch of the adult-use market on October 17, 2018 and expenses related to the Canna Farms acquisition were a material factor in the increase in net loss.

As at September 30, 2018, the Company had $100 million in cash, cash equivalents and short-term investments, total assets of $285 million, total liabilities of $61 million, and 291 million common shares outstanding.

Additional details with respect to the Company’s results of operations are available in its management’s discussion and analysis and condensed interim consolidated financial statements for the period ended September 30, 2018, both of which can be found on SEDAR at www.sedar.com.

Strategic Agreements

Since June 30, 2018, the Company has entered into a number of agreements that will provide a strong platform for future growth, including:

• an agreement with Pharmascience Inc., a global pharmaceutical company based in Montreal that is a Licensed Dealer, to develop a line of specific medical cannabis formulations on behalf of the Company that are intended to maximize therapeutic benefit to patients by using pharmaceutical quality and precise dosing standards
• an applied research agreement with Loyalist College’s Applied Research Centre for Natural Products and Medical Cannabis (ARC) to investigate and develop innovative processes for the extraction and formulation of cannabis oils
• an agreement between Harvest Medicine and Think Research, a leading digital healthcare platform provider, to enhance its national medical cannabis care and education platform
• a multi-year agreement with national cannabis distributor, Green Hedge Education & Distribution Services Ltd., to provide sales and distribution services to licensed cannabis wholesalers and retailers across Canada.

About VIVO Cannabis™

VIVO is recognized for trusted, high-quality products and services. Through Canna Farms and ABcann Medicinals, it holds production and sales licences for cannabis and cannabis oils from Health Canada and operates world-class indoor cultivation facilities with proprietary plant-growing technology. VIVO has a collection of brands targeting unique customer segments, including Beacon Medical™, FIRESIDE™, Canna Farms™ and Lumina™. VIVO acquired Canna Farms, a premium cannabis company based in Hope, British Columbia, in August 2018. Canna Farms was BC’s first Licensed Producer and has several years of craft cultivation experience and expertise.

The Company is significantly expanding its production capacity and pursuing partnership and product development opportunities domestically, as well as in select international markets, including Germany and Australia. In the fourth quarter of 2018, VIVO also acquired THC, which was subsequently amalgamated with Harvest Medicine. Harvest Medicine and THC operate a patient-centric and highly scalable network of specialty medical cannabis clinics in Alberta and on the east coast of Canada, as well as HMED Connect, a free telemedicine service.

VIVO has a healthy balance sheet and is well-positioned to accelerate the growth of its business, in Canada and internationally.

ON BEHALF OF THE BOARD OF DIRECTORS

Barry Fishman (CEO and Director)

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Disclaimer for Forward-Looking Information

All dollar amounts in this news release are in Canadian dollars. Certain statements in this news release are forward-looking statements, which are statements that are not purely historical, including statements regarding the beliefs, plans, expectations or intentions of VIVO and its management regarding the future. Forward-looking statements in this news release include statements relating to the Company’s plans to expand production capacity and pursue partnership and product development opportunities domestically and internationally. Such statements are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the forward-looking statements, including: (i) that the Company may not be able to achieve its production capacity targets at some or all of its production facilities; (ii) that the Company may not be able to launch new products in the time expected or at all; (iii) that the Company may not be able to achieve competitive margins; (iv) that the Company may not be able to increase the sales of its products in the current domestic market or to successfully launch new product lines in the time expected or at all; (v) that new products, if launched, may not be accepted by the market or may become subject to product liability claims; (vi) that the Company may not be able to obtain a distribution/import license or a cultivation license for Germany or other emerging markets it is targeting; (vii) that the Company may not be able to serve larger and broader markets as a result of its production increase; (viii) that the Company may be unable to retain its key talent; and (ix) other factors beyond the Company’s control. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. Readers are urged to consider these factors, and the more extensive risk factors included in the Company’s annual information form dated April 30, 2018, which is available on SEDAR, carefully in evaluating the forward-looking statements contained in this news release and are cautioned not to place undue reliance on such forward-looking statements, which are qualified in their entirety by these cautionary statements. The forward-looking statements in this news release are made as of the date hereof and the Company disclaims any intent or obligation to update publicly any such forward-looking statements, whether as a result of new information, future events or results or otherwise, except as required by applicable securities laws.

$YGYI to Present at the 11th Annual LD Micro Main Event

SAN DIEGO, Nov. 29, 2018  — Youngevity International, Inc. (NASDAQ: YGYI), a leading omni-direct lifestyle company, announced today that its President and Chief Financial Officer, Dave Briskie, will present at the 11th annual LD Micro Main Event at the Luxe Sunset Boulevard Hotel in Los Angeles, CA.

Youngevity is scheduled to present on Wed., Dec. 5, 2018, at 2:00 p.m. PST.  Youngevity will also attend one-on-one meetings with institutional investors throughout the day.

The Youngevity presentation will be webcast and can be followed at http://wsw.com/webcast/ldmicro15/ygyi/. The webcast will be available on Youngevity’s website, YGYI.com, for thirty days.

The LD Micro Main Event is the largest independent conference for small/micro-cap companies and will feature 250 companies presenting to an audience of over 1,200 attendees.

About Youngevity International, Inc.

Youngevity International, Inc. (NASDAQ: YGYI ), is a leading omni-direct lifestyle company — offering a hybrid of the direct selling business model, that also offers e-commerce and the power of social selling. Assembling a virtual Main Street of products and services under one corporate entity, Youngevity offers products from the eight top selling retail categories: health/nutrition, home/family, food/beverage (including coffee), spa/beauty, fashion, essential oils, and photo, as well as innovative services. The Company was formed in the course of the summer 2011 merger of Youngevity Essential Life Sciences with Javalution® Coffee Company (now part of the company’s food and beverage division). For investor information, please visit YGYI.com. Be sure to like us on Facebook and follow us on Twitter.

About LD Micro

LD Micro was founded in 2006 with the sole purpose of being an independent resource in the microcap space. What started out as a newsletter highlighting unique companies has transformed into several influential events annually (Invitational, Summit, and Main Event). In 2015, LDM launched the first pure microcap index (the LDMi) to exclusively provide intraday information on the entire sector. LD will continue to provide valuable tools for the benefit of everyone in the small and micro-cap universe.

For those interested in attending, please contact David Scher at david@ldmicro.com or visit www.ldmicro.com for more information.

Safe Harbor Statement

This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. In some cases, forward-looking statements can be identified by terminology such as “may,” “should,” “potential,” “continue,” “expects,” “anticipates,” “intends,” “plans,” “believes,” “estimates,” and similar expressions. These forward-looking statements are based on management’s expectations and assumptions as of the date of this press release and are subject to a number of risks and uncertainties, many of which are difficult to predict that could cause actual results to differ materially from current expectations and assumptions from those set forth or implied by any forward-looking statements. Important factors that could cause actual results to differ materially from current expectations include, among others, our ability to continue our international growth, our ability to continue our coffee segment growth, our ability to leverage our platform and global infrastructure to drive organic growth, our ability  to improve our profitability, expand our liquidity, and strengthen our balance sheet, our ability to continue to maintain compliance with the NASDAQ requirements, the acceptance of the omni-direct approach by our customers, our ability to expand our distribution, our ability to add additional products (whether developed internally or through acquisitions), our ability to continue our financial performance, and the other factors discussed in our Annual Report on Form 10-K and our subsequent filings with the SEC, including subsequent periodic reports on Forms 10-Q and 8-K. The information in this release is provided only as of the date of this release, and we undertake no obligation to update any forward-looking statements contained in this release on account of new information, future events, or otherwise, except as required by law.

Contacts:

Youngevity International, Inc.
Dave Briskie
President and Chief Financial Officer
1 800 982 3189 X6500

Investor Relations
YGYI investor relations
800.504.8650
investors@ygyi.com

$TGODF Cannabis Global Growth Influencing Rapid Expansion

Palm Beach, FL – (November 29, 2018) — As the cannabis market continues to evolve and experiencing a compounding rate of growth due to factors such as legalization, product advancements and rising consumer interest, cannabis companies are heavily investing in the expansion of operations. Through high levels of private investment, operations within cannabis are expanding as leaders aim for lower costs with higher volumes of output. With millions invested in operations and process optimization, enhanced levels of growth are expected to continue in the multi-billion dollar market. Active cannabis stocks in the markets today include:  CROP Infrastructure Corp. (CSE:CROP) (OTC:CRXPF), The Green Organic Dutchman Holdings Ltd. (TSX:TGOD) (OTC:TGODF), Namaste Technologies Inc. (TSX-V:N) (OTC:NXTTF), Neptune Wellness Solutions Inc. (NASDAQ:NEPT) (TSX:NEPT), HEXO Corp. (TSX:HEXO) (OTC:HYYDF).

CROP Infrastructure Corp. (CSE:CROP) (OTCPK:CRXPF) BREAKING NEWS:  CROP Infrastructure  announced today it has signed a toll processing agreement with a manufacturing company that will produce oils, crumbles and distillates for sale in to the California market.

The raw material will be finished cannabis from CROP’s Humboldt County farm where the cannabis is awaiting sale, being trimmed or drying. The farm is currently flowering 10,000 sqft of canopy for a late stage harvest and is working on the permitting for its 2019 expansion including a proposed 30,000 sq ft automated greenhouse facility.

In addition, a distribution agreement is now in place for the cannabis which will be sold under the company’s Hempire brand for estimated gross revenue of approximately $1,600 per pound of flower. The farm has allocated 750lbs of inventory to be sold under the Hempire brand.

The distributor has offices in Oakland and Orange County. Their distribution network consists of approximately 350 licensed |cannabis stores across California.

CROP CEO, Michael Yorke, stated: “Progress is continuing on becoming fully vertically integrated with self-serving Emerald Heights retail application. Processing and distribution are key agreements in getting our product onto hundreds of potential retail shelves. CROP’s core goal is maximizing its return on investment from tenant 2018 production, while preparing and building relationships for an exciting 2019.”  Read this full announcement and more news for CROP Infrastructure at:    https://www.financialnewsmedia.com/news-crop/

Additional cannabis industry related developments from around the markets:

The Green Organic Dutchman Holdings Ltd. (TSX:TGOD.TO) (OTCQX:TGODF) recently announced a supply partnership with Velvet Management Inc. for sales and distribution to provincial liquor and cannabis boards across Canada. Velvet is a new company with distinct ownership created by the largest wine distributor in Canada, Philippe Dandurand Wines. TGOD is committed to best-in-class distribution for its premium, certified organic cannabis. Sales and relationships with provincial cannabis and liquor boards is a critical aspect to TGOD’s success. Through the partnership with Velvet, TGOD has secured a strong entry point with every provincial liquor and cannabis board across Canada.

Namaste Technologies Inc. (TSX-V:N.V) (OTCQB:NXTTF) recently announced that its wholly-owned subsidiary, Cannmart Inc. (“Cannmart”) has signed a Delivery Agreement (the “Agreement”) to launch much-anticipated same-day delivery service in the Greater Toronto Area (“GTA”) through Pineapple Express Delivery Inc. (“Pineapple Express”) for its medical cannabis products. Effective immediately, Cannmart patients within the GTA area will have access to same-day, set-time, and rushed delivery services. The launch of same-day delivery within Cannmart’s platform further supports the Company’s vision to offer value to its patients in a medical cannabis online marketplace.

Neptune Wellness Solutions Inc. (NASDAQ:NEPT) (TSX:NEPT) recently announced On Thursday, December 6, 2018 , management will present at the LD Micro Main Event XI in Los Angeles, CA , at 9:00 a.m. PST and be available to meet with investors attending the conference that day. A webcast of the presentation session and a copy of the company’s latest investor presentation will be available on the company’s website at https://neptunecorp.com/en/investors/events-and-presentations/.

HEXO Corp. (TSX:HEXO.TO) (OTCPK:HYYDF) recently announced  the closing of the acquisition of its interest in a large facility in Belleville, Ontario. This is the first facility that the Company has established outside of Quebec, further delivering on its national expansion strategy and allowing HEXO to create a centre of excellence for the development of advanced cannabis products. “Closing the transaction and acquiring our interest in this facility is integral to carrying out our hub and spoke business strategy,” said Sebastien St-Louis, HEXO’s CEO and co-founder. “The space can be scaled up based on our future needs and provides HEXO with the infrastructure it needs to continue partnering with Fortune 500 companies and to create category-winning cosmetics, edibles, vapes and more.” The centralized location, conveniently located along primary shipping routes in Ontario, will allow HEXO to process and distribute cannabis-based products to fulfil its commitments across Canada.

DISCLAIMER:  FN Media Group LLC (FNM), which owns and operates FinancialNewsMedia.com and MarketNewsUpdates.com (FNM) is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels.  FNM is NOT affiliated in any manner with any company mentioned herein.  FNM and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security.  FNM’s market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities.  The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material.  All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks.  All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release.  FNM is not liable for any investment decisions by its readers or subscribers.  Investors are cautioned that they may lose all or a portion of their investment when investing in stocks.  For current services performed FNM has been compensated forty nine hundred dollars for news coverage of the current press release issued above by CROP Infrastructure Corp. by a non affiliated third party.  FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNM undertakes no obligation to update such statements.

$SNNVF Releases Q3 2018 Financial Results, Reports Strong Revenue Growth

$NUGS Establishes Landmark Partnership in Cannabis Compliance Matters

LOS ANGELES, Nov. 29, 2018 — Cannabis Strategic Ventures, Inc. (OTC: NUGS) announced a partnership with Feldmann Nagel Cantafio Margulis, PLLC a boutique lawfirm formed in early 2004 by Charles Feldmann and David Nagel, with deep cannabis compliance expertise throughout the United States, Israel, and the international cannabis marketplace. As an extension of the Cannabis Strategic Ventures Team, Charles E. Feldmann, Founding Partner, will lead the legal team on matters related to cannabis enforcement, licensing, federal risk mitigation and compliance related issues at the local, state, national and international level.

Attorney Charles Feldmann was a former federal prosecutor and defense attorney in the United States Marine Corps and a former states narcotics prosecutor in Colorado. He previously served as a Drug Enforcement Agency (DEA) Drug Task Force Commander and is a former lecturer and instructor with the Department of Defense and with the National College of District Attorneys. Feldmann oversees the firm’s international cannabis practice and its military justice international division.

“Cannabis Strategic Ventures is proud to partner with Charles Feldmann and the Feldmann Nagel Cantafio Margulis team for all cannabis compliance related to cultivation, distribution, retail matters for our brands,” said Simon Yu, CEO, Cannabis Strategic Ventures. “The ever-evolving regulatory landscape at the state and national levels, and the increasing number of countries implementing cannabis-friendly legislations, makes it became critically important to have reputable experts on cannabis enforcement, licensing, federal risk mitigation on our team.”

Charles Feldmann stated, “Our law firm looks forward to being a strategic advisor and counselor to Cannabis Strategic Ventures, a publicly traded cannabis corporation, and providing their exceptional team with diverse legal and business expertise.”

Cannabis Strategic Ventures is committed to building category leaders within the cannabis and CBD space. A recent Grandview Research Report states that the global legal marijuana market is expected to reach USD 146.4 billion by the end of 2025 as legal marijuana continues to gain traction worldwide due to very high demand among consumers and increasing legalization of recreational or medical marijuana in various countries. This week, South Korea legalized medical cannabis, laying the foundation for reform in Southeast Asia.

About Cannabis Strategic Ventures
Cannabis Strategic Ventures is a Los Angeles based firm that incubates, develops and partners with category leaders within the cannabis sector. The Firm’s NUGS brand experience provides mentorship and a range of essential services to emerging and existing Cannabis consumer brands. The Company recently completed a name and symbol change from Cascade Energy, Inc. Cannabis Strategic Ventures is publicly traded on the U.S. Over the Counter Market with the stock symbol NUGS.

About Feldmann Nagel Cantafio Margulis, PLLC
Feldmann Nagel Cantafio Margulis has a reputation for achieving exceptional results for clients in a variety of practices around the world. The firm was formed in early 2004 by Charles Feldmann and David Nagel. Charles Feldmann’s roots stem from his training as a JAG prosecutor and defense attorney with the United States Marine Corps and then his transition into state and federal governmental practice as a drug task force commander with the DEA and a local state deputy district attorney. The firm’s attorneys are committed to providing exceptional legal services to their clients and have earned distinctions from a number of professional organizations, including Martindale-Hubbell® and Super Lawyers® Magazine.

FORWARD-LOOKING STATEMENTS: This release contains “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements also may be included in other publicly available documents issued by the Company and in oral statements made by our officers and representatives from time to time. These forward-looking statements are intended to provide management’s current expectations or plans for our future operating and financial performance, based on assumptions currently believed to be valid. They can be identified by the use of words such as “anticipate,” “intend,” “plan,” “goal,” “seek,” “believe,” “project,” “estimate,” “expect,” “strategy,” “future,” “likely,” “may,” “should,” “would,” “could,” “will” and other words of similar meaning in connection with a discussion of future operating or financial performance.

Examples of forward-looking statements include, among others, statements relating to future sales, earnings, cash flows, results of operations, uses of cash and other measures of financial performance.

Because forward-looking statements relate to the future, they are subject to inherent risks, uncertainties and other factors that may cause the Company’s actual results and financial condition to differ materially from those expressed or implied in the forward-looking statements. Such risks, uncertainties and other factors include, among others such as, but not limited to economic conditions, changes in the laws or regulations, demand for products and services of the company, the effects of competition and other factors that could cause actual results to differ materially from those projected or represented in the forward-looking statements. Any forward-looking information provided in this release should be considered with these factors in mind. We assume no obligation to update any forward-looking statements contained in this report.

Contact:
Arlene Guzman
Phone:+1-310-359-6860
Email: ir@cannabisstrategic.com
Website: http://www.cannabisstrategic.com

$PBIO Capitalizing on Ultra Shear Technology, Including in CBD Oil

Interviewing with Proactive Investors, CEO Richard T. Schumacher Also Highlights and Accentuates Importance of Timely Appointment of Dr. Brad Young as Chief Commercial Officer

SOUTH EASTON, MA / November 28, 2018 / Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBI” or the “Company”), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide life sciences and other industries, today announced that Richard T. Schumacher, President and CEO, was interviewed by broadcast journalist Christine Corrado of Proactive Investors, a leading multi-media news organization, investor portal and events management business with offices in New York, Sydney, Toronto, Frankfurt, and London.

Ultra Shear Technology (“UST”), the Company’s proprietary processing method, uniquely combines ultra high pressure with intense shearing forces to potentially create a wide range of high value product innovations for multiple major consumer and industrial markets. During the interview, Mr. Schumacher discussed the two major milestones recently achieved by the Company in its accelerated UST development program. While doing so, he described how the Company recently completed the development of the first working prototype of the UST system and had subsequently used this prototype system to demonstrate a unique and profound capability for making high value oil-based materials dissolve in water. Mr. Schumacher expanded on the Company’s vision for applying this ability to make oils soluble in water, which he believed would allow the Company to enter or serve multiple large and growing markets, including food and beverages, pharmaceuticals, nutraceuticals, and cosmetics.

Responding to Ms. Corrado’s questions, Mr. Schumacher stated that the Company had selected an initial focus for these efforts on the rapidly-growing CBD Oil market, estimated by the Brightfield Group to grow to about $22 billion by 2022. Mr. Schumacher pointed out that water soluble CBD could potentially solve several critical issues currently throttling development of this market, including the need to significantly increase the efficiency of CBD absorption by the body, the need to decrease the cost of CBD production per use, and the need to produce high quality, water soluble CBD with minimized quantities of added chemicals. Mr. Schumacher then discussed why he believes PBI’s proprietary UST platform could successfully meet these requirements.

Mr. Schumacher also devoted considerable attention to discussing the recent addition of the Company’s new Chief Commercial Officer, Dr. Bradford A. Young, including an overview of Dr. Young’s blend of scientific and business education and leadership experience. Mr. Schumacher underlined his excitement for the contribution he anticipated from Dr. Young in developing and implementing a new commercialization strategy for the Company that could successfully drive product adoption and accelerate revenue growth. Mr. Schumacher concluded by noting that Dr. Young and he had begun to explore potential opportunities in the CBD space and that they had received strong interest from several groups with whom they had spoken.

Jeffrey N. Peterson, PBI’s Board Chairman , stated: “We are very pleased to have had the opportunity to share the Company’s recent milestones with a rapidly expanding, worldwide audience of potential investors, partners, customers, and collaborators. Proactive Investors is a well-respected, far-reaching multi-media news organization with the ability to effectively broadcast the corporate stories investors need to hear. We appreciated the insightful interview opportunity with Christine Corrado and we hope that many of their viewers will have the opportunity to watch this milestone interview. Ric Schumacher does an excellent job of explaining the expected impact of our powerful new UST platform, in conveying our excitement for the potential of this proprietary system to be a game-changer in the CBD/cannabinoids and other marketplaces, and in discussing the potential impact that the UST platform could have on our future revenue and growth.”

Click here to access the video interview.

About Pressure BioSciences, Inc.

Pressure BioSciences, Inc. (OTCQB: PBIO) is a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences industry. Our products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or “PCT”) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions (e.g., cell lysis, biomolecule extraction). Our primary focus is in the development of high pressure-based products for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, food science, soil & plant biology, forensics, and counter-bioterror applications. Additionally, PBIO is actively expanding the use of our pressure-based technologies in the following areas: (1) the use of our recently acquired PreEMT technology from BaroFold, Inc. to allow entry into the biologics manufacturing and contract research services sector, and (2) the use of our recently-patented, scalable, high-efficiency, pressure-based Ultra Shear Technology (“UST”) platform to (i) create stable nanoemulsions of otherwise immiscible fluids (e.g., oils and water) and to (ii) prepare higher quality, homogenized, extended shelf-life or room temperature stable low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies.

Forward Looking Statements

This press release contains forward-looking statements. These statements relate to future events or our future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our or our industry’s actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed, implied or inferred by these forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may,” “will,” “should,” “could,” “would,” “expects,” “plans,” “intends,” “anticipates,” “believes,” estimates,” “predicts,” “projects,” “potential” or “continue” or the negative of such terms and other comparable terminology. These statements are only predictions based on our current expectations and projections about future events. You should not place undue reliance on these statements. In evaluating these statements, you should specifically consider various factors. Actual events or results may differ materially. These and other factors may cause our actual results to differ materially from any forward-looking statement. These risks, uncertainties, and other factors include, but are not limited to, the risks and uncertainties discussed under the heading “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2017, and other reports filed by the Company from time to time with the SEC. The Company undertakes no obligation to update any of the information included in this release, except as otherwise required by law.

For more information about PBI and this press release, please click on the following website link:

http://www.pressurebiosciences.com

Please visit us on Facebook, LinkedIn, and Twitter.

Investor Contacts:

Richard T. Schumacher, President and CEO (508) 230-1828 (T)
Jeffrey N. Peterson, Chairman of the Board (650) 812-8121 (T)

$PFSF Aims to Streamline Trade Between Brazil and China

$SNNVF Q3 2018 Financial Results, Strategic Update on Canadian Operations

Third Quarter Highlights 

• Revenue of $3.8 million with gross margin of 56%
• Year to date revenue of $13.4 million, up over 30% year over year
• Initial operations and revenue from the Extraction Facility (as defined below)
• Closed $23 million bought deal financing (the “Offering”)

VANCOUVER, British Columbia, Nov. 28, 2018 – Sunniva Inc. (“Sunniva”, the “Company”, “we”, “our” or “us”) (CSE:SNN) (OTCQB:SNNVF), a North American provider of cannabis products and services, today released its financial and operational results and management’s discussion and analysis for the three and nine months for the third quarter of 2018 ended September 30, 2018. All figures are reported in Canadian dollars ($) unless otherwise stated. Sunniva’s financial statements are prepared in accordance with International Financial Reporting Standards.

“We continue to make progress towards completion of Phase 1, the first 325,000 square feet, of our purpose built, high-technology cannabis greenhouse in Cathedral City, California.  While we have remained committed to advancing our operations in order to play a leadership role in the California cannabis market as we launch our first Sunniva branded products in the first quarter of 2019, we have maintained solid performance of our existing operations with $3.8 million in revenue and gross margins of 56% in the third quarter.  We have now generated year to date revenue of $13.4 million, a 30 percent increase over this same period last year,” said Anthony Holler, Chief Executive Officer of Sunniva.

“With our strategic assets in place in California, we are now in a position to accelerate our revenue growth by advancing upon our upstream vertical opportunities.  We will soon demonstrate our ability to become one of the lowest cost operators producing pesticide-free, premium quality cannabis products, and achieving true vertical integration by:

• leveraging our purpose built, large-scale, high technology cGMP designed greenhouse in Cathedral City (the “Sunniva California Campus”);
• accelerating production within our licensed volatile and non-volatile extraction facility in Cathedral City, California (the “Extraction Facility”);
• producing and stockpiling inventory for Sunniva-branded product launches commencing Q1 2019;
• completing the pending acquisition of LTYR Logistics, LLC (“LTYR”) for state-wide distribution of Sunniva-branded products;
• aggressively pursuing dispensary retail expansion throughout California; and
• integrating our additions to the California management team to facilitate growth and revenues in 2019.

Dr. Holler continued, “In Canada, we concluded our formal engagement with Canaccord Genuity Corp. to conduct a thorough examination of the Canadian cannabis market to define Sunniva’s strategy for our Canadian operations. We can confirm the Company intends to spin-out its Canadian assets (the “Spin-Out”) into a separate Canadian entity (“Spinco”).  Our Canadian assets include Natural Health Services Ltd. (“NHS”), which owns our seven physician-based medical clinics throughout Canada and Sunniva Medical Inc. (“SMI”), which is our licensed producer applicant and owns the 126-acre parcel of land in Okanagan Falls, British Columbia, the site for a large-scale, purpose-built cGMP designed greenhouse (the “Sunniva Canada Campus”).”

Financial Highlights – Three and Nine Months Ended September 30, 2018

Consolidated Financial Highlights expressed in 000’s of CDN$, except per share amounts

Results of Operations – Three Months Ended September 30, 2018

For the three and nine months ended September 30, 2018, the Company generated $3.7 million and $13.4 million in revenue, respectively. NHS contributed $2.5 million and $8.4 million, Full-Scale Distributors, LLC (“FSD”) contributed $1.1 million and $4.9 million, and CP Logistics, LLC contributed $0.1 million over these same periods. Net loss for the three and nine months ended September 30, 2018 was $6.8 million and $18.0 million as compared to $6.3 million and $18.0 million during the three and nine months ended September 30, 2017.

The key components contributing to the change in net loss from the three and nine months ended September 30, 2018 compared to the prior comparative periods comprise the following:

• Revenue decreased by $0.8 million during the three months ended September 30, 2018 and increased by $3.2 million during the nine months ended September 30, 2018 as compared to the respective comparative periods.  NHS revenue decreased by $0.7 million during the three months ended September 30, 2018 due to a decline in the number of prescriptions written over the comparative period; however, NHS revenue increased by $1.0 million during the nine months ended September 30, 2018 due to an increase in the number of clinics and Licensed Producers (“LPs”) under contract over the comparative period.  FSD revenue decreased slightly by $0.2 million during the three months ended September 30, 2018 but increased by $2.1 million during the nine months ended September 30, 2018 due to an increased customer base and strong first quarter 2018 results.  The increase over the comparative nine months ended September 30, 2017 is also due to the acquisitions of NHS and FSD midway through February 2017.
• Gross margin increased by $0.4 million and $2.8 million during the three and nine months ended September 30, 2018 primarily due to the increase of LP revenue in NHS.  LP revenue provides the highest margin of all the Company’s revenue streams.  On a percentage basis, gross margin increased from 38% and 41% in the three and nine months ended September 30, 2017 to 56% and 52% in the three and nine months ended September 30, 2018 due to the increase in LP revenue.
• Selling, general and administration expenses increased by $1.3 million and $7.1 million during the three and nine months ended September 30, 2018.  The increase is primarily due to an increase in operational spend with the Company’s continued expansion, higher costs associated with being a publicly-listed company and increased advisory costs related to the development of the cultivation businesses in California and Canada.   The most significant increase in costs relate to professional fees, personnel costs and rent.  The increase over the comparative period is also due to the acquisitions of NHS and FSD occurring midway through the first quarter of fiscal 2017.
• Share-based payment expenses were $2.3 million and $6.4 million in the three and nine months ended September 30, 2018 compared to $3.3 million in the three and nine months ended September 30, 2017 with the introduction of the Company’s stock option plan mid-way through fiscal 2017.
• The Company realized a non-cash gain of $1.0 million on settlement of a secured convertible promissory note issued in connection with the acquisition of FSD in the first quarter of fiscal 2018.
• Fair value changes in derivative instruments due to the revaluation of secured convertible promissory notes and warrants went from a gain of $0.3 million and an expense of $8.7 million for the three and nine months ended September 30, 2017 to gains of $1.1 million and $0.8 million for the three and nine months ended September 30, 2018.  This was due to a decrease in the Company’s share price in the third quarter of fiscal 2018 and significant fair value changes in fiscal 2017 with the Company’s private share value increasing throughout fiscal 2017.
• Amortization and depreciation expense increased by $0.1 million and $0.4 million during the three and nine months ended September 30, 2018 due to a higher cost base of the assets in fiscal 2018 and the intangible assets being acquired midway through the first quarter of fiscal 2017.

• The Company’s cash position is $11.2 million as of the date hereof.

Recent Operating Developments Subsequent to September 30, 2018

• On October 12, 2018, the Company completed the Offering for aggregate gross proceeds of $23.0 million.  A total of 4,370,000 units were sold at a price of $5.27 per unit. The Company intends to use the net proceeds from the Offering for construction and operations at the Sunniva Canada Campus and Sunniva California Campus, with the remaining amount funding working capital.
• On October 16, 2018, the Company signed a letter of intent with a related party, the Oakland Vision Project (“Vision”), to acquire all the issued and outstanding equity interests of the companies that comprise Vision. Vision is jointly owned by Vinayak Shastry, the Company’s President of U.S. Operations.  Vision operates a licensed cultivation facility located in Oakland, California (the “Oakland Facility”) and currently has a contract to supply the Sunniva California Campus with clean clones to initiate production. Completion of the acquisition remains subject to a number of conditions including, among other things: the negotiation and execution of a definitive agreement between the Company and Vision, completion of due diligence and receipt of regulatory approvals, including approval of the Canadian Securities Exchange.
• In November 2018, the Company transitioned from the OTCQX to the OTCQB as a consequence of the decrease in the Company’s share price on the OTCQX which resulted in the Company no longer meeting the qualification requirement that it relied on for the purposes of listing.  The Company will continue to trade under the symbol “SNNVF” and it will have no effect on the reporting obligations of the Company in the United States.
• On November 26, 2018, the Company signed a binding letter of intent with LTYR, a cannabis distribution company in California that is expected to become Sunniva’s logistics and technology distribution platform to drive sales from Sunniva’s large-scale cannabis production and manufacturing facilities and the launch of Sunniva-branded products commencing Q1 2019.  LTYR will also utilize Sunniva’s Cathedral City distribution and delivery license.  The principal members of LTYR will also perform key management and sales roles in California.  LTYR will continue to generate revenues and expand its existing relationships with over 120 licensed dispensaries throughout California.  Concurrently, Sunniva is purchasing a 4,200 sq. ft warehouse in Long Beach, California that, once licensed and operational, will serve as an additional distribution hub for Sunniva and will expand the Company’s distribution reach from the southern border to San Francisco.  The City of Long Beach is a cannabis friendly region and the warehouse is situated in an industrial district that has been zoned for cannabis business operations.  Renovations and receipt of licensing requirements are expected to be completed in Q2 2019.  Completion of the acquisition remains subject to a number of conditions including, among other things: the negotiation and execution of a definitive agreement between the Company and LTYR, completion of due diligence and receipt of regulatory approvals, including approval of the Canadian Securities Exchange.

Copies of our interim financial statements for the three and nine months ended September 30, 2018 and related management’s discussion and analysis of financial results are available on SEDAR at www.sedar.com.

California Operations Update

• Construction is nearing completion for Phase 1 of the Sunniva California Campus and is expected to be completed in Q1 2019. Total production capacity of Phase 1 is projected to be 50,000 kg (50 million grams) per year of premium indoor cannabis when fully ramped up.  A total of 100,000 plants from the Oakland Facility are being prepared for onboarding for the initial planting cycle in Q1 2019.  Automation will move the plants through their life cycle and when operating at full capacity, the Sunniva California Campus is expected to deliver a continuous daily harvest of approximately 210 kg (2.1 million grams) of dried flower. We continue to work toward the completion of our California state licensing requirements for the Sunniva California Campus. The cultivation licenses are currently being processed and the remaining license applications are being prepared for submission to the state of California. The Company does not expect operational delays from these licensing requirements.  The Sunniva California Campus will be a 489,000 sq. ft. state-of-the-art, purpose-built cGMP facility capable of producing 72,500 kg (72.5 million grams) per year of dried flower at peak capacity once construction of Phase 2 is completed.
• The Extraction Facility, licensed for both volatile and non-volatile extraction processes, commenced operations in July 2018. The extraction team has been manufacturing and perfecting its extracted product lines and developing product formulations.  Sunniva is currently stockpiling inventory in preparation for the launch of Sunniva-branded product lines in Q1 2019.  The Extraction Facility has the ability to produce vape oil-distillate, ultra-pure concentrates, fresh frozen, shatter, capsules, tinctures, and edibles.  The Extraction Facility adheres to cGMP standards and has the capacity to process over 10,000 lbs of cannabis biomass a month.  Sunniva continues to source compliant third-party biomass and trim through existing relationships which will drive revenues in early 2019.  Reliance on purchases of third-party biomass will be reduced as production from the Sunniva California Campus becomes available.
• We have been evaluating many retail expansion opportunities to complement our vertical integration strategy.  In addition to the flagship dispensary being built at the Sunniva California Campus, our goal is to pursue other retail acquisitions to expand our footprint in this part of the integration chain.
• Sunniva has strengthened its California management team in preparation for full operations in 2019.  We have hired Kevin Wilkerson as COO of California operations, Tom Brozowski as Vice President Operations, Andrew Pruett as Vice President of Technology, Jay Myers as Vice President of Sales, Brad Neeld as Vice President of Distribution and Victor Ide, Manager of Human Resources.

Canada Operations Update

• Our business strategy in Canada will shift from becoming a wholesaler of cannabis to a focus on the higher margin direct to patient medicinal cannabis market. Currently in Canada, there are approximately 400,000 registered cannabis patients, with that number forecasted to grow to over two million registered patients in the next three years.  NHS has 105,000 registered patients to date and with 100% ownership of seven physician-based clinics across Canada, we feel we have a significant competitive advantage in capturing additional market share in this area.
• We have defined a clear path to accelerate our licensing and production timelines through SMI at the Sunniva Canada Campus by starting construction of a smaller modular phased approach that will require less than $1.5 million in cash capital expenditures.  Production from this modular phase will be key to achieving our goal of 20,000 registered patients in 2019 and over 50,000 in 2020.  We intend to increase future production capacity through phased development of the Sunniva Canada Campus.
• The Company intends to spin out its Canadian assets into Spinco and apply to list the shares of Spinco on the TSX Venture Exchange (“TSX-V”) first half of 2019.

Spin-Out Steps and Anticipated Timelines

• Borden Ladner Gervais LLP has been engaged to handle the legal aspects of the Spin-Out including outlining the steps, timeline, preparation of the information circular and making the necessary regulatory and court applications.
• PricewaterhouseCoopers LLP has been engaged as tax advisors to conduct the tax assessment and valuation of the Spin-Out to determine the allocation of value of the Canadian and US entities.
• MNP LLP has been retained as the auditors to conduct the audit of the carve-out financial statements of Spinco.
• Q1 2019 – set record date and mail out of information circular which will include information on the management, board of directors and financial statements of Spinco.
• Q1/Q2 2019 – meeting of the shareholders to vote on the transaction.
• Q2 2019 – shares of Spinco expected to begin trading on the TSX-V.

Canada Business Plan

• Sunniva has the infrastructure to capture significant market share within the medicinal cannabis market:
  • Market estimated to reach over two million patients in the next three years
  • Insurance companies and unions providing medical cannabis coverage under group benefit plans
  • Physicians are the gatekeepers to achieving market share
  • High margin, LP direct to patient distribution business model
  • BMO Capital Markets estimate medical sales price of $8.50 per gram for the next three years with the current average patient spend of $2,000 per year
• Patient capture through 100% ownership of NHS cannabis clinics and technology platform:
  • Seven specialized brick and mortar cannabis clinics in four provinces (AB, SK, MB, ON)
  • Over 105,000 registered patients
  • 18 health care professionals (GPs, specialists) and two nurse practitioners
  • Creating an online virtual e-commerce clinic platform for education, telemedicine and sales
  • Planned collaboration with universities for research and development
• SMI received Confirmation of Readiness for a cultivation license under the Access to Cannabis for Medical Purposes Regulation from Health Canada on May 26, 2018 – SMI’s application is approved and subject to initial phased build and readiness
• Phase 1 – Modular fast- tracked facility (planned flower capacity ~5,000 kg/year)
  • New cultivation modules expected to be delivered to site January 2019
  • Cannabis genetics already sourced for production
  • Submit for cultivation license approval – January 2019
  • Estimate registering 20,000 medical patients in 2019, over 50,000 in 2020
  • Estimated costs < $2.50/gram pharma-grade, pesticide-free producer
  • Initial capital of $1.5 million with additional production modules to be vendor financed
  • Estimate receipt of sales license and first harvest by Q3 2019
• Phase 2 – 458,000 sq. ft (50,000 kg per year flower capacity)
  • State-of-the-art, purpose built, cGMP designed greenhouse
  • Low cost < $1.00/gram pharma-grade, pesticide-free producer
  • Subject to financing and license approvals
• Phase 3 – 301,000 sq. ft (50,000 kg per year flower capacity)
  • State-of-the-art, purpose built, cGMP designed greenhouse
  • Low cost < $1.00/gram pharma-grade, pesticide-free producer
  • Subject to financing and license approvals

Please see the updated Corporate Presentation and Fact Sheet at www.Sunniva.com/Investors/

To be added to the Sunniva email distribution list, please email Sunniva@kcsa.com with Sunniva in the subject line.

About Sunniva Inc.

Sunniva, through its subsidiaries, is a vertically integrated cannabis company operating in the world’s two largest cannabis markets – Canada and California. Our ability to leverage our large-scale, purpose-built cGMP designed greenhouses, offering better quality assurance with cannabis products free from pesticides, uniquely positions Sunniva as a leading supplier of safe, high quality products at scale. Through our strategically positioned cultivation and extraction facilities, we are launching Sunniva-branded products in various product categories including premium concentrates, vape cartridges, flower, pre-rolls, and beverages as well as aggressively pursuing upstream vertical opportunities including distribution and retail expansion. Sunniva’s management and board of directors have a proven track record for creating significant shareholder value both in the healthcare and biotech industries.

For more information please visit: www.sunniva.com

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

This press release contains forward-looking statements within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, statements regarding the Company’s operations and growth opportunities, the Company’s expansion of its footprint in the U.S., the Company’s vision to become one of the lowest cost, highest quality vertically integrated cannabis producers in the markets we serve by building large scale purpose-built current cGMP designed greenhouses and expansion of retail locations, offering better quality assurance with cannabis products free from pesticides, providing better customer access to cannabis education and sourcing better therapeutic delivery devices, the profitability of the Company’s facilities and operating subsidiaries, the expected dramatic increase in demand for cannabis in Canada following legalization of cannabis, the costs and expected production at the Sunniva California Campus and the Sunniva Canada Campus, the timing and conditions relating to the Spin-Out, the Sunniva California Campus being operational in Q1 2019 with the first harvest expected in Q2 2019, the ability of the Company to launch Sunniva-branded product lines in California and propagate the Sunniva California Campus with clean clones, the conditions of closing for the acquisition of Vision, the conditions of closing for the acquisition of LTYR, the expectation that LTYR will continue to generate revenues and expand its existing relationships with over 120 licensed dispensaries throughout California, the timing of renovations and receipt of licensing requirements for the warehouse in Long Beach, California, the impact of the transaction with LTYR on the Company and LTYR’s expected role as the Company’s logistics and technology distribution platform, the Company’s expectation that there will be no operational delays from the California licensing requirements for the Sunniva California Campus, the Company’s anticipated production and brand roll-out at the Extraction Facility, the reduction of reliance on purchases of third-party biomass as production from the Sunniva California Campus becomes available, the Company’s goal to pursue other retail acquisitions in California, the Company’s shift in focus from becoming a wholesaler of cannabis to the direct to patient medicinal cannabis market in Canada, the expected growth of the number of registered cannabis patients in Canada, the estimated medical sales price for the next three years and average patient spend, the Company’s expected use of proceeds from financings, and statements regarding the plans, timing and conditions of the Spin-Out, are “forward-looking statements.” Forward-looking statements can be identified by the use of words such as “plans”, “expects” or “does not expect”, “is expected”, “estimates”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or statements that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results, events or developments to be materially different from any future results, events or developments expressed or implied by such forward-looking statements. Such risks and uncertainties include, among others, the risk factors included in the Sunniva’s continuous disclosure documents available on www.sedar.com. These factors should be considered carefully, and readers are cautioned not to place undue reliance on such forward-looking statements. Although Sunniva has attempted to identify important risk factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other risk factors that cause actions, events or results to differ from those anticipated, estimated or intended. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in forward-looking statements. Sunniva assumes no obligation to update any forward-looking statement, even if new information becomes available as a result of future events, new information or for any other reason except as required by law.

Company Contact:

Dr. Anthony Holler
Chairman and Chief Executive Officer
Phone: (866) 786-6482

Investor Contact:                                                          Media Contact:
Phil Carlson / Erika Kay                                                  Katelyn Tumino
KCSA Strategic Communications                                   KCSA Strategic Communications
Phone: (212) 896-1233                                                   Phone: (212) 896-1252
Email: pcarlson@kcsa.com / ekay@kcsa.com               Email: ktumino@kcsa.com

$PNNRF Cannabis Strategic Ventures, Water-Soluble Cannabis Technology JD

VANCOUVER, British Columbia, Nov. 28, 2018 — Redfund Capital Corp (CSE: LOAN) (Frankfurt: O3X4) (OTC: PNNRF) is pleased to announce that portfolio client Biolog Inc. has formed a partnership with Cannabis Strategic Ventures, Inc. (OTC:NUGS), to develop water-soluble cannabis technologies to be used as ingredients for cannabis and phytocannabinoid rich-infused foods, beverages and consumer products.  Under the agreement, Biolog will develop the new technologies with Cannabis Strategic Ventures and will jointly deploy marketing efforts to get the products to the marketplace.

Cannabinoids (CBD, etc.) are hydrophobic substances which are not typically soluble in water. To date, cannabis formulators have utilized various techniques to make CBD oils water compatible, but encounter many drawbacks in the existing processes. The joint development effort between Biolog Inc. and Cannabis Strategic Ventures will seek to push past these current limitations to develop a new set of functional cannabinoid ingredients that can be easily added to foods, beverages, cosmetics and other consumer products that significantly improve bioavailability and overall benefits to the human body.

Simon Yu, CEO, Cannabis Strategic Ventures comments, “We believe water-soluble cannabis technologies open new avenues for the development of cannabinoid-based products.”  He added,  “Over the past year we have reviewed several supposed water-soluble cannabinoids technologies but have passed on adoption due to technological limitations. The new product class that is in development with Biolog holds great potential and we are enthusiastically backing this developmental effort.”

“Working alongside Cannabis Strategic Ventures and assisting them to realize their mandate building their products brands using Biolog technology shows collaboration of incubators in the space. Branded products are the niche we believe will lead the industry just as patented medical products lead pharma for many decades. Biolog’s licensing agreements with Lexaria makes them a leader of the medical cannabis pack. This client in our portfolio looks to be our next go-public prodigy,” stated Meris Kott, CEO, Redfund Capital Corp.

About Redfund Capital

Redfund intends to provide debt and equity funding in the mid-to-late stages of a target company’s development, or in technologies that are developed and validated by revenues. The present focus of the merchant bank is on medical cannabis, hemp and CBD-related, healthcare-related target companies.

About Cannabis Strategic Ventures

Cannabis Strategic Ventures is a Los Angeles based firm that incubates, develops and partners with category leaders within the cannabis sector. The Firm’s NUGS brand experience provides mentorship and a range of essential services to emerging and existing Cannabis consumer brands.

About Biolog, Inc.

Privately held Biolog, Inc., located in the San Francisco Bay area, has been organized to capitalize on the fast growing market for cannabidiol (CBD) edibles and beverages. Biolog products solve many of the industry’s most pressing issues concerning cannabis edibles and beverages by offering precise dosing, micro-dosing, fast onset times, high bioavailability, taste masking and ease of use.

For further information on Redfund Capital please visit www.redfundcapital.com
For more information on Redfund Capital contact Meris Kott CEO 604.484.8989 or info@redfundcapital.com

For further information on Cannabis Strategic Ventures, Inc. please contact Arlene Guzman Phone:+1-310-359-6860 Email: ir@cannabisstrategic.com
Website: http://www.cannabisstrategic.com

Further information about the Company is available on www.SEDAR.com under the Company’s profile.

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release. Certain statements contained in this release may constitute “forward–looking statements” or “forward-looking information” (collectively “forward-looking information”) as those terms are used in the Private Securities Litigation Reform Act of 1995 and similar Canadian laws. These statements relate to future events or future performance. The use of any of the words “could”, “intend”, “expect”, “believe”, “will”, “projected”, “estimated”, “anticipates” and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the Company’s current belief or assumptions as to the outcome and timing of such future events. Actual future results may differ materially. In particular, this release contains forward-looking information relating to the business of the Company, the Property, financing and certain corporate changes. The forward-looking information contained in this release is made as of the date hereof and the Company is not obligated to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties and assumptions contained herein, investors should not place undue reliance on forward-looking information. The foregoing statements expressly qualify any forward-looking information contained herein.

$RIV.V 420 with CNW – Cannabis PTSD Study Finally Secures Target Number of Participants

$TGODF Expansion of CBD – Hemp Continues to Explode as Demand, Sales Revenues Climb

Palm Beach, FL – (October 2, 2018) – While there may have been a recent pull back on Cannabis stocks, one thing that remains strong is the grow operations show no signs of slowing and instead continue to expand.  The cannabis industry’s growth is forcing industry cannabis focused companies to evaluate the current state of their operations, both in terms of scale and efficiency. Despite market conditions, more importantly as demand rises and retail sales improve, companies are still choosing to expand operations with investment and innovation. Driving the demand could also be attributed to the change in federal policy in the U.S. and recent legalization of recreational marijuana in Canada.  According to Bill Sumner, a Hemp Business Journal contributor, as the industry impatiently awaits passage of the 2018 Farm Bill and pending removal of hemp from the Controlled Substances Act, companies are quickly moving to position themselves as leading suppliers of hemp-based CBD products, and investors are all too happy to help foot the bill.  Active cannabis companies in the markets this week include Global Hemp Group Inc. (CSE:GHG) (OTC:GBHPF), Aurora Cannabis Inc. (NYSE:ACB) (TSX:ACB), Liberty Health Sciences Inc. (CSE:LHS) (OTC:LHSIF), GW Pharmaceuticals plc (NASDAQ:GWPH), The Green Organic Dutchman Holdings Ltd. (TSX:TGOD) (OTC:TGODF).

Global Hemp Group Inc. (CSE:GHG.CN) (OTCPK:GBHPF) BREAKING NEWS:  Global Hemp Group and its joint venture partner Marijuana Company of America, Inc. (OTC:MCOA) (the “Partners”) are pleased to provide an update on the harvest at their high yielding CBD hemp project in Scio, Oregon.

The 2018 Scio cultivation consisted of 33 acres of high yielding CBD hemp (utilizing six different cultivars with an expected CBD content ranging from 6% to 12%) was grown in an orchard style cultivation on the two lower fields at the property. With the help of near perfect weather in the region extending the harvest period by several weeks, the hemp had the opportunity to grow to full maturity and allowed the team to completely harvest all plants grown, before the fall rains began in the valley. For pictures from this season’s cultivation, please visit the Scio project page on GHG’s website – https://globalhempgroup.com/scio-oregon.

As with most things on the hemp farm this year, innovation was the key to success. There were many challenges throughout the year; from getting a late start due to delays in closing of the farm acquisition, to preparing the fields, drying, harvesting and storage, but the team in Scio was able to find solutions when required. Our team consists of a number of crew members that are extremely innovative, who are trained in a variety of skill sets. They are well versed in everything from metal fabrication, fine carpentry, and large equipment operation, so the team is able to set up, build, and/or operate pretty much everything themselves at the project. With the addition of a number of knowledgeable advisers to assist, the team was able to solve all challenges that arose during the course of the season.

The Harvest – This year’s harvest consisted of approximately 37,000 high yielding CBD hemp plants producing 24 tons of biomass. Harvesting this year was done by hand, making it extremely labour intensive and time consuming. The team has created a number of solutions that will automate both the harvesting and planting of the hemp for next year’s crop. Ultimately, the goal is to completely automate these processes, making it more efficient and less costly to complete. The team has now begun working on prototypes to automate the harvesting processes and expect to have machinery ready for use next season.

Drying – A number of different drying techniques were employed with this year’s harvest. In the end, “old school” hanging techniques proved to be the most effective and efficient. Drying took place in the farm’s larger 20 foot high, 4,000 sq. ft. greenhouses which allowed for an increased quantity of plants being dried at any one time. Drying took approximately 36 to 48 hours to dry the hemp to be levels required for storage and ultimately extraction. With each successive batch of drying, techniques were improved to increase the volume of biomass being dried in the greenhouse, while decreasing the time that it took to hang and dry it.

Results – The drying process for all of the hemp harvested is now complete and is stored awaiting further processing. The farm produced 48,000 pounds of dried biomass, which is stockpiled in quarter ton super sacks, stacked three bags high and requiring approximately 4,000 sq. ft. of storage space. Despite the late start in planting this season, the hemp plants still achieved sufficient size to produce the anticipated quantity of biomass. It is expected that in 2019, planting will begin June 1^st giving the hemp an addition 30-45 days of growing time. This will produce much larger plants, resulting in significantly larger quantities of biomass.   Read this and more news for Global Hemp Group at http://www.financialnewsmedia.com/news-ghg

Other recent developments in the cannabis industry include:

Liberty Health Sciences Inc. (CSE:LHS.CN) (OTCQX:LHSIF) recently announced it plans to open two new dispensaries in Miami and Dania Beach by the end of November and three more in Hollywood, Bonita Springs and Orange Park by the end of this December. Each of the dispensaries will feature free 24-hour delivery service throughout their service area. The new dispensaries are located at 6827 Bird Road, Miami, FL.; 1103 South Federal Highway, Dania Beach, FL.; 2119A Hollywood Blvd., Hollywood, FL.; 24611 Production Circle, Bonita Springs, FL.; 1907-3 Wells Road, Orange Park, FL. The dispensaries are open Monday through Friday, 10 a.m. to 7p.m., Saturday, 10 a.m. to 5 p.m., and Sunday 12 p.m. to 5 p.m. Currently, Liberty operates seven dispensaries and six delivery hubs throughout Florida. By the end of the calendar year, Liberty plans to have 12 dispensaries open throughout the state, subject to the receipt of Florida Department of Health approvals.

Aurora Cannabis Inc. (NYSE:ACB) (TSX:ACB) announced last week the completion of the previously announced plan of arrangement (the “Arrangement”) pursuant to which Aurora has acquired all of the issued and outstanding common shares of ICC for $1.95 per share (payable in common shares of Aurora (the “Aurora Shares”)), reflecting an aggregate purchase price of approximately $290 million . ICC is now a wholly-owned subsidiary of Aurora. Completion of the Arrangement follows receipt of approval of the Arrangement from the Instituto de Regulación y Control del Cannabis, the Uruguayan regulatory authority overseeing the regulation and control of cannabis in Uruguay. ICC’s common shares will be delisted from the TSX Venture Exchange (the “TSX-V”), subject to TSX-V approval, and applications will be made for ICC to cease being a reporting issuer. The acquisition of ICC establishes Aurora as the industry leader in Latin American, a region which encompasses more than 650 million people from across Mexico , the Caribbean , Central America , and South America . ICC, based in Uruguay , the first country in the world to legalize cannabis for adult consumer use, has developed a strong portfolio of high-quality, low-cost production assets, product offerings, and commercial agreements.

GW Pharmaceuticals plc (NASDAQ:GWPH) recently announced positive top-line results of the second randomized, double-blind, placebo-controlled Phase 3 clinical trial of EPIDIOLEX® (cannabidiol or CBD) CV in the treatment of seizures associated with Dravet syndrome, a rare and severe form of childhood-onset epilepsy. In this trial, EPIDIOLEX, when added to the patient’s current treatment, achieved the primary endpoint of reduction in convulsive seizures for both dose levels (10 mg/kg per day and 20 mg/kg per day) with high statistical significance compared to placebo. Both EPIDIOLEX doses also demonstrated statistically significant improvements on all key secondary endpoints. “The positive outcome in this second trial of EPIDIOLEX in patients with Dravet syndrome further reinforces the effectiveness of this newly available medicine in this particularly difficult to treat, childhood-onset epilepsy,” stated Ian Miller, M.D., Director, Epilepsy and Neurophysiology Program at Nicklaus Children’s Hospital in Miami, FL and principal investigator of the trial. “The totality of data from the controlled clinical trials completed for EPIDIOLEX have shown clinically meaningful seizure reductions and a consistent safety and tolerability profile. I am excited that this recently approved and important new treatment option is now available for my patients.”

The Green Organic Dutchman Holdings Ltd. (TSX:TGOD.TO) (OTCQX:TGODF) recently announced a supply partnership with Velvet Management Inc. for sales and distribution to provincial liquor and cannabis boards across Canada. Velvet is a new company with distinct ownership created by the largest wine distributor in Canada, Philippe Dandurand Wines. TGOD is committed to best-in-class distribution for its premium, certified organic cannabis. Sales and relationships with provincial cannabis and liquor boards is a critical aspect to TGOD’s success. Through the partnership with Velvet, TGOD has secured a strong entry point with every provincial liquor and cannabis board across Canada.

DISCLAIMER:  FN Media Group LLC (FNM), which owns and operates Financialnewsmedia.com and MarketNewsUpdates.com, is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels.  FNM is NOT affiliated in any manner with any company mentioned herein.  FNM and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security.  FNM’s market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities.  The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material.  All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks.  All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release.  FNM is not liable for any investment decisions by its readers or subscribers.  Investors are cautioned that they may lose all or a portion of their investment when investing in stocks.  For current services performed FNM has been compensated twenty four hundred dollars for news coverage of the current press releases issued by Global Hemp Group Inc. by a non-affiliated third party.  FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNM undertakes no obligation to update such statements.

$SNNVF Acquisition of California Distribution Company Primes Branded Cannabis Products

• LTYR Logistics, LLC to become Sunniva’s logistics and technology distribution platform to drive sales from Sunniva’s large-scale cannabis production facilities, following the launch of Sunniva branded products commencing Q1 2019
• Sunniva acquires highly skilled management and sales team with a retail network of more than 120 licensed retail dispensaries throughout California
• Compliant distribution is a vital segment of the highly regulated California cannabis industry with track and trace implementation coming in January 2019. For all movement of cannabis products in California, distributors are subject to additional responsibility for product testing and safety as well as state tax collection

VANCOUVER, British Columbia, Nov. 27, 2018  — Sunniva Inc. (“Sunniva” or the “Company”) (CSE: SNN) (OTCQB: SNNVF), today announced the acquisition of 100% of LTYR Logistics, LLC (“LTYR”) (the “Acquisition”), a California-based cannabis distribution company headquartered in San Diego. LTYR’s strong leadership and proven ability to effectively execute growth strategies utilizing its distribution capabilities within the cannabis space are the primary drivers of this acquisition. LYTR will play an instrumental role in driving Sunniva’s leadership position in California as a truly vertically integrated cannabis company across the entire value chain, from seed to sale.

Kevin V. Wilkerson (CEO) leads the LTYR team and has joined Sunniva as the Chief Operating Officer of Sun CA Holdings, Sunniva’s 100% owned California operating subsidiary. Mr. Wilkerson is a Harvard Masters degree graduate and has been a successful entrepreneur in numerous businesses. Kevin has been active in the cannabis space since 2014, providing operations, distribution logistics and technology expertise to the industry. He retired as a Colonel in the US Army after a distinguished 24 year career where he commanded over 4,000 troops and received the Bronze Star. In connection with the acquisition, Mr. Wilkerson will be responsible for all of Sunniva’s California operations.

The other co-founders of LTYR have also joined Sunniva in various management roles. Jay Myers will become Vice President of Sales in California and Brad Neeld will become Vice President of Distribution. Mr. Myers has operated in sales within the cannabis space in both Colorado and California since 2012 following a successful executive management, sales/marketing, and leadership career for companies such as West Coast Consulting and Bank of America. Prior to that, he served 12 years as a Navy SEAL. Mr. Neeld was one of the first large-scale commercial cultivators in Colorado before entering distribution in California. His retail relationships and cultivation knowledge reach far beyond distribution strategies and include scientific aspects of the cannabis core DNA and molecular strain structure.

“Over the last six months, we have evaluated several distribution opportunities to complement our vertical integration strategy with the goal of being able to sell all of the products we produce in our California facilities. Our operations and marketing teams have been working closely with the LTYR team analyzing consumer market data, demand metrics and pricing economics to better define all upcoming Sunniva product lines in preparation of our brand launches commencing in the first quarter of 2019. Kevin and his team are proven distribution, operations and execution specialists and we have the utmost confidence in their distribution capabilities as Sunniva ramps up for large-scale production in 2019 from both of our high-tech greenhouse and extraction facilities,” said Dr. Anthony Holler, CEO of Sunniva. “Over the past quarter, we have been actively manufacturing and stockpiling inventory for our brand launches and we are excited about achieving significant revenue from all our vertical growth opportunities in 2019.”

Kevin Wilkerson, CEO of LTYR Logistics added, “One of the biggest challenges that distribution companies in California are experiencing is getting access to compliant, pesticide-free cannabis products on a large-scale. Compliant cultivation at scale is the quintessential pillar in California for the future success of any brand, distribution company or retail chain. We are very excited to join a preeminent partner like Sunniva that will ensure safe, reproducible, premium-quality cannabis products on a very large scale. After touring both Sunniva’s 325,000 square foot purpose-built cannabis greenhouse and the extraction facility in Cathedral City, we were very impressed with the level of meticulous design and implementation of top tier commercial agriculture technologies and automation. While we had a variety of opportunities available to us, partnering with Sunniva was the most logical choice for our shareholders to take our business to the next level.”

LTYR – Further Information

• Revenue generating and operating in partnership under a third-party distribution license in Northern California
• LTYR to utilize Sunniva’s existing Cathedral City distribution and delivery license
• Sunniva purchasing a 4,200 sq. ft. proposed distribution facility in Long Beach, CA
• Fully automated sorting, weighing, packaging machines for large-scale distribution
• Additional distribution platform for real-time delivery solutions
• LTYR to be compliant with “track and trace” regulations coming January 2019 to California

LTYR – Transaction Details

• Binding term sheet signed for the acquisition of 100% of the equity interests of LTYR
• Consideration: 1,861,971 of Sunniva common shares at CAD $4.26 per share with 620,657 of such shares to be subject to achieving operational milestones
• Expected Closing Date by the end of Q4 2018. Closing is subject to conditions, including negotiation and execution of definitive agreement, receipt of any required approvals, and satisfactory completion of due diligence.

About Sunniva Inc.

Sunniva, through its subsidiaries, is a vertically integrated cannabis company operating in the world’s two largest cannabis markets – Canada and California. Our ability to leverage our large-scale, purpose-built cGMP designed greenhouses, offering better quality assurance with cannabis products free from pesticides, uniquely positions Sunniva as a leading supplier of safe, high quality products at scale. Through our strategically positioned cultivation and extraction facilities, we are launching Sunniva branded products in various product categories including flower, pre-rolls, premium concentrates, vape cartridges, edibles and beverages. We will have inhouse compliant distribution and continue to aggressively pursue retail expansion in the near term in California. Sunniva’s management and board of directors have a proven track record for creating significant shareholder value both in the healthcare and biotech industries.

This news release includes statements containing certain “forward-looking information” within the meaning of applicable securities law (“forward-looking statements”), including, but not limited to, statements relating to the proposed benefits of the Acquisition and the plans for Sunniva, and statements with respect to the conditions of completing the Acquisition, including negotiating and executing the definitive agreement and regulatory approvals. Forward-looking statements are frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or statements that certain events or conditions “may” or “will” occur. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.

Company Contact:
Dr. Anthony Holler
Chairman and Chief Executive Officer
Phone: (866) 786-6482

Investor Contact:
Phil Carlson / Erika Kay
KCSA Strategic Communications
Phone: (212) 896-1233
Email: pcarlson@kcsa.com / ekay@kcsa.com

Media Contact:
Katelyn Tumino
KCSA Strategic Communications
Phone: (212) 896-1252
Email: ktumino@kcsa.com

$NUGL Scales Broad Launch Into the Cannabis Industry

LOS ANGELES, Nov. 27, 2018 — via NEWMEDIAWIRE — NUGL Inc. (OTC: NUGL) (the “Company”), the cannabis industry’s new standard of technology, is pleased to announce a full-scale marketing launch into the cannabis industry from all NUGL platforms and publications.

“We have listened to our community and made the proper changes to the software.  We have tested all marketing campaigns and we are now ready to aggressively scale these efforts.  It is time to get the word out there and allow us to connect businesses and consumers in a highly efficient manner,” stated Ryan Bartlette, Chief Marketing Officer at NUGL.

NUGL has created a broad network of social media influencers, combined traffic and users from the acquisition of two publications and is in the process of launching NUGL Magazine, a new culture-based publication in the cannabis space.  The coordinated launch of NUGL Magazine and collective assets is expected to increase online, monetizable visitors by the millions and generate a viral push.

NUGL has also ramped attention through various media companies such as Money TV, a leading investment network where NUGL was featured last week.  NUGL has been asked to participate in a follow-up show updating the network on location from a dispensary in Los Angeles called “Da Spot” at Circle of Life Dispensary operated by Chonsie Bullock.

“We are excited about NUGL and integrating the software into our business.  NUGL offers unique tools to network and grow sales. Nothing like this has ever been done in the cannabis space,” stated Bullock.

NUGL intends to penetrate the market in a significant way, bypassing the conventional ways of the cannabis industry markets.   With three growing, influential publications and software with proprietary and unparalleled networking features, NUGL is positioning itself for rapid expansion in 2019.

About NUGL

NUGL is the world’s first cannabis search app built for the people, by the people. Our goal is to build the most user-friendly app experience in the cannabis industry by listening to our users and giving them what they want. NUGL is the only cannabis search app that offers equal and unbiased search results. We don’t sell top-spot listings or fake reviews, so our data stays true. Use NUGL to search for genuine user-rated dispensaries, strains, doctors, lawyers, cannabis service providers, vape shops, hydro stores, brands and more. NUGL’s flexible web app has no geographic limitations and can rapidly connect cannabis companies, related vertical services and users. The NUGL iOS and Android app brings a powerful cannabis search tool within reach of anyone, anytime, anywhere with the ease of a smartphone.

For more information and updates, visit one of the links below.

Website: http://www.nugl.com/
Facebook:  https://www.facebook.com/nuglapp/
Instagram: https://www.instagram.com/nuglapp/
Twitter: https://twitter.com/nuglapp/

LinkedIn: https://www.linkedin.com/company/nuglapp/

Newsletter: https://nugl.us16.list-manage.com/subscribe?u=219fe8bb6995a19827c9f36cb&id=dc46712578

Forward-Looking Statements

Certain statements in this press release may be considered “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements may include projections of matters that affect revenue, operating expenses or net earnings; projections of growth; and assumptions relating to the foregoing. Such forward-looking statements are generally qualified by terms such as: “plans”, “anticipates,” “expects,” “believes” or similar words of like kind. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or qualified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking information. These factors are discussed in greater detail in the company’s business plan and filings with the OTC Markets Group.

Contact Information:

Website: www.nugl.com
Email: info@nugl.com
Phone: (714) 383-9982

Investor Relations & Financial Media

info@integrityir.com

Toll Free: (888) 216-3595

www.IntegrityIR.com

$DPW Authorizes Pursuit of Spinoff of Super Crypto Mining

NEWPORT BEACH, Calif., Nov. 27, 2018 — DPW Holdings, Inc. (NYSE American: DPW), a diversified holding company (“DPW,” or the “Company”), announced today that its Board of Directors, at a meeting on Friday, November 23, 2018, has authorized the officers of DPW to pursue a spinoff of DPW’s wholly-owned subsidiary Super Crypto Mining, Inc. (“Super Crypto”). The Company’s action demonstrates its confidence in the long-term viability of crypto-mining and the cryptocurrency marketplace and endeavors to provide Super Crypto’s management team the tools and independence necessary to achieve and surpass its goals in 2019 and beyond. The Company intends to declare a distribution of shares of common stock of Super Crypto to the stockholders of DPW, with the date of the distribution to be determined once a registration statement on Form 10 has been declared effective by the SEC and the information statement has been mailed to DPW’s stockholders. DPW believes that the spinoff will benefit both DPW and Super Crypto as well as their respective stockholders for many reasons, with the principal ones consisting of the following:

  •         The separation of the two businesses should not only enable their respective management teams to concentrate on the operations of the company for which they are responsible but also facilitate analysts’, market makers’ and others’ ability to ascertain the value of each entity and thus provide more clarity to the market through, among other reasons, being able to review two separate financial statements which could in turn lead to higher valuations for each entity;

           •         Investors, including portfolio managers and other institutional investors, who are interested in the cryptocurrency sector could initiate, maintain, or increase their position in Super Crypto, whereas investors who are not interested could take the alternate approach; as a result, the spinoff could enhance both companies’ ability to raise financing to expand their operations, among other objectives;

           •         Since a new board of directors would be established for Super Crypto, the members thereof should bring more expertise in the cryptocurrency sector to bear on their decision-making, and enable the members of the DPW Board of Directors to focus on a business with which they are more familiar; this in turn should lead to additional benefits such as a better allocation of capital and human resources; and

          •         Once spun off, Super Crypto should be able to use its shares as currency to pursue a variety of objectives, an option not presently available to it as DPW owns all its shares of its capital stock.

Any plan that the Company devises will be subject to approval by DPW’s senior secured creditor and certain regulatory bodies.

CEO and Chairman, Milton “Todd” Ault, III said, “As stated during our investor conference call on December 20, 2017, the acquisition of assets that would appreciate under our ownership and the creation of increased shareholder value through our portfolio companies and projects was our top priority. By spinning off our cryptocurrency assets, we are separating disparate businesses and providing the opportunity to hold stock in a pureplay crypto company. We are confident crypto-mining and the cryptocurrency marketplace will flourish in the long term and think there is significant value in Super Crypto and its various initiatives which require the ability to finance their growth independently. Regardless of the current downturn in the cryptocurrency space, we believe the assets of Super Crypto will be able to serve as the foundation of an independent company with the ability to raise its own capital. Further, this transaction positions Super Crypto Mining for a bitcoin recovery. It is our intent to declare a special dividend of no less than 80% of the common stock of Super Crypto to DPW stockholders.”

For more information, DPW recommends that stockholders, investors and any other interested parties read the Company’s public filings and press releases available under the Investor Relations section at www.DPWHoldings.com or available at www.sec.gov.

About DPW Holdings, Inc.

DPW Holdings, Inc. is a diversified holding company pursuing growth by acquiring undervalued businesses and disruptive technologies with a global impact. Through its wholly owned subsidiaries and strategic investments, the Company provides mission-critical products that support a diverse range of industries, including defense/aerospace, industrial, telecommunications, medical, crypto-mining, and textiles. In addition, the company owns a select portfolio of commercial hospitality properties and extends credit to select entrepreneurial businesses through a licensed lending subsidiary. DPW Holdings, Inc.’s headquarters is located at 201 Shipyard Way, Suite E, Newport Beach, CA 92663; www.DPWHoldings.com.

Forward-Looking Statements

This press release contains “forward looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as “believes,” “plans,” “anticipates,” “projects,” “estimates,” “expects,” “intends,” “strategy,” “future,” “opportunity,” “may,” “will,” “should,” “could,” “potential,” or similar expressions. Statements that are not historical facts are forward-looking statements. Forward-looking statements are based on current beliefs and assumptions that are subject to risks and uncertainties. Forward-looking statements speak only as of the date they are made, and the Company undertakes no obligation to update any of them publicly in light of new information or future events. Actual results could differ materially from those contained in any forward-looking statement as a result of various factors. More information, including potential risk factors, that could affect the Company’s business and financial results are included in the Company’s filings with the U.S. Securities and Exchange Commission, including, but not limited to, the Company’s Forms 10-K, 10-Q and 8-K. All filings are available at www.sec.com and on the Company’s website at www.DPWHoldings.com.

Contacts: 
Mary Magnani and Kirsten Chapman, LHA Investor Relations, 415.433.3777, dpwholdings@lhai.com###

$VVCIF 420 with CNW – Marijuana No Effect on Kidney Transplant Outcomes, Research

$TGODF CBD Products on the Rise

POINT ROBERTS, Wash. and DELTA, British Columbia, Nov. 26, 2018 — Investorideas.com, a leading investor news resource covering security and cannabis stocks releases a snapshot looking at the growing global opportunity for CBD consumable products as regulations move towards global acceptance of CBD products.

Cannabis is fast becoming a growing sector, both in the medicinal and recreational sectors. As much as certain states and countries have begun to regulate this potential giant industry, CBD and specifically hemp strains of cannabis have begun to overshadow the general cannabis sector.

Seeing the opportunity at the start of 2018, EnviroTechnologies International, Inc., a publicly traded company (OTC: ETII) that develops and markets green, natural and organic products for diverse industries first announced the acquisition of CBD Health Co. (www.cbdhealthco.com), a company that markets and sells high quality and proprietary hemp-based, natural CBD health products, as a wholly owned subsidiary.

One of the products that uniquely position them as a public company is the CBD Hemp Protein, which caters to the health and sports markets. According to an article discussing its benefits “hemp—one of the most versatile plants on earth—offers a high-quality, eco-friendly source that can support muscle gain, fat loss, and peak performance.”

EnviroTechnologies International updated shareholders on this acquisition in today’s news. “We acquired CBD Health Co. because our company was founded to use green and natural products to make our environment safer and promote products that improve our quality of life,” said Gaylord Karren, ETI’s CEO. “And CBD Oil products have the potential to not only improve quality of their users’ lives but also create enormous revenues for our company and its shareholders.”

Continued: “For some time, experts have been making predictions about the global CBD market and the expanding acceptance of CBD as a natural health product. And some have predicted, specifically that the entire cannabis market could reach $20 billion by 2020 if the market expands at its current rate,” said Randall Waters, ETI’s Vice President of Sales and Marketing. “However, recent studies by the Brightfield Group, a company that specializes in providing data and information about the cannabis and CBD markets, avers that the hemp-based CBD market alone could reach $22 billion by 2022.”

Continued: “We see the markets for true hemp-based CBD products such as those produced by CBD Health, continuing to grow and the purchasing demographic multiplying over the next 3-4 years. We are satisfied that CBD Health is on the forefront of this incredible market and that we can tap into this new, accepted hemp-based CBD natural products,” said Waters.

Puration, Inc. (OTC: PURA), another company in the CBD space, recently released more details regarding its corporate restructuring to concentrate resources on its rapidly expanding cannabis infused beverage business.

Puration, Inc. is a leading Texas-based CBD-infused beverage provider, with the flagship product being EVERx, which Puration debuted early last year at Arnold Schwarzenegger’s ‘Arnold Sports Festival’.  EVERx has since become the leading CBD infused beverage in the sports nutrition marketplace. The Company recently spun-off its cannabis cultivation segment to focus its efforts exclusively on its high-growth core CBD-infused beverage business.

CV Sciences Inc. (OTC:CVSI), operates as a life science company through two segments, Specialty Pharmaceuticals and Consumer Products. The company focuses on developing and commercializing prescription drugs utilizing synthetic cannabidiol (CBD) as the active pharmaceutical ingredient. Its initial drug candidate is CVSI-007 that combines CBD and nicotine for the treatment of smokeless tobacco use and addiction. The company also engages in the development, manufacture, marketing and sale of consumer products containing plant-based CBD under the PlusCBD Oil name in various market sectors, including nutraceutical, beauty care, specialty foods and vape.

CEO Joseph Dowling discussed the company’s Q3 Earnings Report earlier this month saying that, “The momentum from the first half of 2018 has continued and we anticipate a strong finish for the remainder of the year. Through our dedication and commitment to providing the most trusted brand of hemp CBD products we have achieved strong momentum in sales and brand recognition of our plus CBD product line. Our strategic priorities for 2018 include strengthening our distribution channels, growing our brand relevance and recognition, developing new products, penetrating new vertical sales channels and gaining market share in the fastest growing product category in the nutritional supplement industry.”

Even larger scale companies such as the Green Organic Dutchman Holdings Ltd. (TSX:TGOD) (OTC:TGODF) earlier this year expanded their CBD output by signing a definitive agreement to acquire 100% of the issued and outstanding shares of privately-held HemPoland.

HemPoland is a leading European manufacturer and marketer of premium organic CBD oils led by founder and CEO, Maciej Kowalski, one of Europe’s most widely recognized CBD experts. This strategic acquisition provides access to HemPoland’s vast distribution network, premium Cannabigold brand, state-of-the-art hemp oil extraction technologies and provides a strategic pathway into the European market for TGOD’s medical & recreational products and licensing deals.

As the CBD trend continues to rise, companies may realize the benefit of focusing strictly on the CBD/Hemp sector. Often noted as a sleeping giant in discussions, consumer awareness and education, plus potential legislative acceptance moves, including the 2018 Farm Bill, will make this a big story for investors moving forward.

For investors following cannabis stocks, Investor Ideas has created a stock directory of publicly traded CSE, TSX, TSXV, OTC, NASDAQ, NYSE, ASX Marijuana/Hemp Stocks

About Investorideas.com – News that Inspires Big Investing Ideas
https://www.investorideas.com/About/

Follow us on Cannabis Social Media
https://www.facebook.com/Investorideaspotcasts/
https://twitter.com/MJInvestorIdeas
https://www.instagram.com/potcasts_investorideas/

This news is published on the Investorideas.com Newswire – News that Inspires big ideas Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp. Disclosure: this news article featuring ETII is a paid for news release on Investorideas.com – third party , Learn more about costs and our  services https://www.investorideas.com/News-Upload/

Additional info regarding BC Residents and global Investors: Effective September 15 2008 – all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.

Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.

Contact Investorideas.com
800-665-0411